Section 13

EurekaMag PDF full texts Chapter 12,136


Laska, M.; Hernandez-Salazar, L.-Teresa 2004: Gustatory responsiveness to monosodium glutamate and sodium chloride in four species of nonhuman primates. Journal of Experimental Zoology 301A(11): 898-905
Thoeny, H.C.; De Keyzer, F.; Claus, F.G.; Sunaert, S.; Hermans, R. 2005: Gustatory stimulation changes the apparent diffusion coefficient of salivary glands: initial experience. Radiology 235(2): 629-634
Welge-Lüssen, A.; Drago, J.; Wolfensberger, M.; Hummel, T. 2005: Gustatory stimulation influences the processing of intranasal stimuli. Brain Research 1038(1): 69-75
May, O.L.; Hill, D.L. 2006: Gustatory terminal field organization and developmental plasticity in the nucleus of the solitary tract revealed through triple-fluorescence labeling. Journal of Comparative Neurology 497(4): 658-669
Moll, F.; Rathert, P. 2005: Gustav Simon - Surgery of the kidneys, vol 1. Printed by Ferdinand Enke Publishing House, Erlangen, 1871. Der Urologe. Ausgabe A 44(2): 169-173
Nijveldt, R.J.; Siroen, M.P.C.; Teerlink, T.; van Lambalgen, A.A.; Rauwerda, J.A.; van Leeuwen, P.A.M. 2004: Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia. Liver International: Official Journal of the International Association for the Study of the Liver 24(5): 510-518
Skea, G.L.; Mountfort, D.O.; Clements, K.D. 2005: Gut carbohydrases from the New Zealand marine herbivorous fishes Kyphosus sydneyanus (Kyphosidae), Aplodactylus arctidens (Aplodactylidae) and Odax pullus (Labridae). Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 140(2): 259-269
Littrell, B.M.; Thomas, C.; Williams, C.S.; Bonner, T.H. 2003: Gut content analysis of the headwater catfish Ictalurus lupus from two west Texas streams. Texas Journal of Science 55(4): 323-328
Villalejo-Fuerte, M.; Muneton-Gomez, M.-Del-Socorro; Garate-Lizarraga, I.; Garcia-Dominguez, F. 2005: Gut content, phytoplankton abundance and reproductive season in the black oyster (Hyotissa hyotis, Linne, 1758) at Isla Espiritu Santo, Gulf of California. Journal of Shellfish Research 24(1): 185-190
Bolstad, K.S.; O'shea, S. 2004: Gut contents of a giant squid Architeuthis dux (Cephalopoda: Oegopsida) from New Zealand waters. New Zealand Journal of Zoology 31(1): 15-21
Bloom, S.; Wynne, K.; Chaudhri, O. 2005: Gut feeling--the secret of satiety?. Clinical Medicine 5(2): 147-152
Johnson, A.T.; Kaufmann, Y.; Luo, S.; Babb, K.; Hawk, R.; Klimberg, V.Suzanne. 2003: Gut glutathione metabolism and changes with 7,12-DMBA and glutamine. Journal of Surgical Research 115(2): 242-246
Perez-Tilve, D.; Nogueiras, R.; Mallo, F.; Benoit, S.C.; Tschoep, M. 2006: Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism. Endocrine 29(1): 61-71
Tjellström, B.; Stenhammar, L.; Högberg, L.; Fälth-Magnusson, K.; Magnusson, K.-E.; Midtvedt, T.; Sundqvist, T.; Norin, E. 2005: Gut microflora associated characteristics in children with celiac disease. American Journal of Gastroenterology 100(12): 2784-2788
Khan, W.I.; Collins, S.M. 2006: Gut motor function: immunological control in enteric infection and inflammation. Clinical and Experimental Immunology 143(3): 389-397
Sankaran, S.; Guadalupe, M.; Reay, E.; George, M.D.; Flamm, J.; Prindiville, T.; Dandekar, S. 2005: Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proceedings of the National Academy of Sciences of the United States of America 102(28): 9860-9865
Laubitz, D.; Jankowska, A.; Sikora, A.; Woliński, Jław.; Zabielski, R.; Grzesiuk, E. 2006: Gut myoelectrical activity induces heat shock response in Escherichia coli and Caco-2 cells. Experimental Physiology 91(5): 867-875
Uneyama, H.; Tanaka, T.; Torii, K. 2004: Gut nutrient sensing by the abdominal vagus. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 124(4): 210-218
Takaki, M. 2003: Gut pacemaker cells: the interstitial cells of Cajal (ICC). Journal of Smooth Muscle Research 39(5): 137-161
Boersma, M.; Wiltshire, K., H. 2006: Gut passage of phosphorus-limited algae through Daphnia: do they take up nutrients in the process?. Archiv fur Hydrobiologie 167(1-4): 489-500
Malagon, I.; Onkenhout, W.; Klok, G.; van der Poel, P.F.H.; Bovill, J.G.; Hazekamp, M.G. 2004: Gut permeability in paediatric cardiac surgery. British Journal of Anaesthesia 94(2): 181-185
Assimakopoulos, S.F.; Vagianos, C.E.; Zervoudakis, G.; Filos, K.S.; Georgiou, C.; Nikolopoulou, V.; Scopa, C.D. 2004: Gut regulatory peptides bombesin and neurotensin reduce hepatic oxidative stress and histological alterations in bile duct ligated rats. Regulatory Peptides 120(1-3): 185-193
Anonymous 2005: Gut tutorial: chronic diarrhoea. Gut 54(2): 296
Heijboer, A.C.; Pijl, H.; Van den Hoek, A.M.; Havekes, L.M.; Romijn, J.A.; Corssmit, E.P.M. 2006: Gut-brain axis: regulation of glucose metabolism. Journal of Neuroendocrinology 18(12): 883-894
Krieg, C.; Maier, R.; Meyerhans, A. 2004: Gut-homing (alpha(4)beta(7)(+)) Th1 memory responses after inactivated poliovirus immunization in poliovirus orally pre-immunized donors. Journal of General Virology 85(Pt 6): 1571-1579
Mittal, R.D.; Kumar, R. 2004: Gut-inhabiting bacterium Oxalobacter formigenes: role in calcium oxalate urolithiasis. Journal of Endourology 18(5): 418-424
Senthil, M.; Brown, M.; Xu, D.-Z.; Lu, Q.; Feketeova, E.; Deitch, E.A. 2006: Gut-lymph hypothesis of systemic inflammatory response syndrome/multiple-organ dysfunction syndrome: validating studies in a porcine model. Journal of Trauma 60(5): 958
Steinmann, Horst-Henning 2005: Gute fachriche Praxil und integrierter Ackerbau im langjahrigen betriebswirtschaftlichen Vergleich. Berichte ueber Landwirtschaft 83(3): 352-375
Pal, S.; Wu, L. 2005: Guts and glory: balancing microbes and the immune response. Developmental Cell 8(1): 1-2
Nacar, N.; Kiper, N.; Dogru, D.; Ozcelik, U.; Ozon, A.; Cobanoglu, N. 2005: Guvercin besleyenlerin pnomonisi olan bir cocukta inhale steroid tedavisi. Cocuk Sagligi ve Hastaliklari Dergisi 48(4): 330-333
Bonifacino, J., M.; Sancho, G. 2004: Guynesomia (Asteraceae: Astereae), a new genus from Central Chile. Taxon 53(3): 673-678
Wislowska, M.; Klimowicz, K. 2006: Guz neuroendokrynny u pacjentki chorej na reumatoidalne zapalenie stawow - opis przypadku. Reumatologia 44(1): 56-59
Van-Den-Boom, P.P.G.; Vezda, A. 2005: Gyalecta canariensis sp nov., a new lichen (Ascomycota) from La Palma (Canary Islands). Mycotaxon 92: 255-258
Flakus, A. 2005: Gyalecta peziza (Gyalectaceae, lichenized Ascomycota), first record in the Polish Tatry Mts. Biologia (Bratislava) 60(4): 373-375
Lendemer, J., C.; Lucking, R. 2004: Gyalideopsis moodyae (Ostropales: Gomphillaceae), a new lichen species from eastern North America. Bryologist 107(2): 234-236
Yu, D.; Eldred, W.D. 2005: Gycine and GABA interact to regulate the nitric oxide/cGMP signaling pathway in the turtle retina. Visual Neuroscience 22(6): 825-838
An, H.-Jin; Cho, I.-Young; Jung, Y.-Sam; Yoon, K.-Hyeon; Kim, H.-Min; Hong, S.-Heon; Shin, S.-Shik 2005: Gyeongshinhae Gihwan T1 has controlling effects on the factors associated with obesity. Journal of Applied Pharmacology 13(1): 7-12
Milanowski, D.J.; Gustafson, K.R.; Rashid, M.A.; Pannell, L.K.; McMahon, J.B.; Boyd, M.R. 2004: Gymnangiamide, a cytotoxic pentapeptide from the marine hydroid Gymnangium regae. Journal of Organic Chemistry 69(9): 3036-3042
Dat, N.Tien.; Van Kiem, P.; Cai, X.Fu.; Shen, Q.; Bae, K.; Kim, Y.Ho. 2004: Gymnastone, a new benzofuran derivative from Gymnaster koraiensis. Archives of Pharmacal Research 27(11): 1106-1108
Ogawa, Y.; Sekita, K.; Umemura, T.; Saito, M.; Ono, A.; Kawasaki, Y.; Uchida, O.; Matsushima, Y.; Inoue, T.; Kanno, J. 2004: Gymnema sylvestre leaf extract: a 52-week dietary toxicity study in Wistar rats. Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan 45(1): 8-18
Izutani, Y.; Murai, T.; Imoto, T.; Ohnishi, M.; Oda, M.; Ishijima, S. 2005: Gymnemic acids inhibit rabbit glyceraldehyde-3-phosphate dehydrogenase and induce a smearing of its electrophoretic band and dephosphorylation. Febs Letters 579(20): 4333-4336
Honsell, G.; Talarico, L. 2004: Gymnodinium chlorophorum (Dinophyceae) in the Adriatic Sea: electron microscopical observations. Botanica Marina 47(2): 152-166
Williamson, K., E.; Powell, R. 2004: Gymnophthalmus underwoodi Grant. Catalogue of American Amphibians and Reptiles 793: 1-5
Holec, J.; Antonin, V.; Graca, M.; Moreau, P.A.thur 2003: Gymnopilus igniculus: Find from the Czech Republic and notes on its variability. Czech Mycology 55(3-4): 161-172
Aleffi, M.; Sabovljevic, M.; Tacchi, R. 2004: Gymnostomum lanceolatum M.J. Cano, Ros & J. Guerra (Pottiaceae, Musci), new to Italy. Cryptogamie Bryologie 25(2): 175-177
Von-Ellenrieder, N.; Garrison, R., W. 2005: Gynacantha Rambur, 1842 and Triacanthagyna Selys, 1883 (Insecta, Odonata): proposed conservation of usage by designation of Gynacantha nervosa Rambur, 1842 as the type species of Gynacantha. Bulletin of Zoological Nomenclature 62(Part 1): 14-17
Anonymous 2006: Gynacantha Rambur, 1842 and Triacanthagyna Selys, 1883 (Insecta, Odonata): usage conserved by the designation of Gynacantha nervosa Rambur, 1842 as the type species of Gynacantha. Bulletin of Zoological Nomenclature 63(Part 2): 136-137
Trapero-Quintana, Adrian-David 2005: Gynacantha ereagris (Gundlach, 1888), un endemico antillano (Odonata). Boletin de la S 36: 353-354
Nakonechnaya, O.V.; Golpenchenko, T.Y.; Koren, O.G.; Zhuravlev, A.N. 2006: Gynaeceum and Androecium structure of Aristolochia manshuriensis (Aristolochiaceae). Rastitel'nye Resursy 42(3): 37-41
Wilson, C.H.; Griffith, C.D.M.; Shrimankar, J.; Douglas, F. 2004: Gynaecomastia, neurofibromatosis and breast cancer. Breast 13(1): 77-79
Creyghton, W.M.; Custers, M. 2004: Gynaecomastia: is one cause enough?. Netherlands Journal of Medicine 62(7): 257-259
Kakizawa, H.; Toyota, N.; Hieda, M.; Hirai, N.; Tachikake, T.; Matsuura, N.; Fujimura, Y.; Kodama, I.; Hirata, E.; Hara, T.; Ito, K. 2006: Gynecologic abscess: CT-guided percutaneous drainage. Hiroshima Journal of Medical Sciences 55(3): 97-100
Lu, K.H.; Dinh, M.; Kohlmann, W.; Watson, P.; Green, J.; Syngal, S.; Bandipalliam, P.; Chen, L.-M.; Allen, B.; Conrad, P.; Terdiman, J.; Sun, C.; Daniels, M.; Burke, T.; Gershenson, D.M.; Lynch, H.; Lynch, P.; Broaddus, R.R. 2005: Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstetrics and Gynecology 105(3): 569-574
Carter, J.; Rowland, K.; Chi, D.; Brown, C.; Abu-Rustum, N.; Castiel, M.; Barakat, R. 2005: Gynecologic cancer treatment and the impact of cancer-related infertility. Gynecologic Oncology 97(1): 90-95
You, W.; Dainty, L.A.; Rose, G.S.; Krivak, T.; McHale, M.T.; Olsen, C.H.; Elkas, J.C. 2005: Gynecologic malignancies in women aged less than 25 years. Obstetrics and Gynecology 105(6): 1405-1409
Scribner, D.R.; Baldwin, J.; Mannel, R.S. 2005: Gynecologic oncologists' perceptions of fellowship training. Journal of Reproductive Medicine 50(1): 29-34
Benedetti-Panici, P.; Angioli, R. 2004: Gynecologic oncology specialty. European Journal of Gynaecological Oncology 25(1): 25-26
Ozalp, S.; Tanir, H.M.; Gurer, H. 2006: Gynecologic problems among elderly women in comparison with women aged between 45-64 years. European Journal of Gynaecological Oncology 27(2): 179-181
Gomez-Lobo, V.; Burgansky, A.; Kim-Schluger, L.; Berkowitz, R. 2006: Gynecologic symptoms and sexual function before and after liver transplantation. Journal of Reproductive Medicine 51(6): 457-462
Canobbio, M.M.; Perloff, J.K.; Rapkin, A.J. 2005: Gynecological health of females with congenital heart disease. International Journal of Cardiology 98(3): 379-387
Parker, D.Y.; Burke, J.J.; Gallup, D.G. 2004: Gynecological surgery in octogenarians and nonagenarians. American Journal of Obstetrics and Gynecology 190(5): 1401-1403
Fugh-Berman, A.; Scialli, A.R. 2006: Gynecologists and estrogen: an affair of the heart. Perspectives in Biology and Medicine 49(1): 115-130
Brummitt, K.; Harmanli, O.H.; Gaughan, J.; Dandolu, V.; Chatwani, A.J.; Hernandez, E. 2006: Gynecologists' attitudes toward hysterectomy: is the sex of the clinician a factor?. Journal of Reproductive Medicine 51(1): 21-25
Nassar, A.H.; Abd Essamad, H.M.; Awwad, J.T.; Khoury, N.G.; Usta, I.M. 2005: Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era. Maturitas 52(1): 18-25
Biglia, A.; Blanco, J.L.; Martínez, E.; Domingo, P.; Casamitjana, R.; Sambeat, M.ía.; Milinkovic, A.; Garcia, M.; Laguno, M.; Leon, A.; Larrousse, M.; Lonca, M.; Mallolas, J.; Gatell, J.M. 2004: Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 39(10): 1514-1519
Di Lorenzo, G.; Perdonà, S.; De Placido, S.; D'Armiento, M.; Gallo, A.; Damiano, R.; Pingitore, D.; Gallo, L.; De Sio, M.; Autorino, R. 2005: Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy. Journal of Urology 174(6): 2197-2203
Prezioso, D.; Piccirillo, G.; Galasso, R.; Altieri, V.; Mirone, V.; Lotti, T. 2004: Gynecomastia due to hormone therapy for advanced prostate cancer: a report of ten surgically treated cases and a review of treatment options. Tumori 90(4): 410-415
García-Benayas, T.; Blanco, F.; Martín-Carbonero, L.; Valencia, E.; Barrios, A.; González-Lahoz, J.; Soriano, V. 2003: Gynecomastia in HIV-infected patients receiving antiretroviral therapy. Aids Research and Human Retroviruses 19(9): 739-741
Bembo, S.A.; Carlson, H.E. 2004: Gynecomastia: its features, and when and how to treat it. Cleveland Clinic Journal of Medicine 71(6): 511-517
Saravia-Toledo, J.-Antonio; Monteros-Alvi, M.; Molina-Lohezic, V.; Leon, M.; Guerrero, A.; Giardino, V. 2006: Gynecomastia: retrospective study of 54 cases surgically treated. Prensa Medica Argentina 93(2): 69-76
Hong, S.-Pyo; Moon, H.-Kyoung 2003: Gynodioecy in Lycopus maackianus Makino (Lamiaceae) in Korea: Floral dimorphism and nutlet production. Flora (Jena) 198(6): 461-467
Merrett, M.F. 2005: Gynodioecy in Teucridium parvifolium (Verbenaceae), a threatened, small-leaved shrub from New Zealand. New Zealand Journal of Botany 43(3): 613-617
Weckerle, C., S.; Rutishauser, R. 2005: Gynoecium, fruit and seed structure of Paullinieae (Sapindaceae). Botanical Journal of the Linnean Society 147(2): 159-189
Bonatti, P.M.; Sgarbi, E.; Del Prete, C. 2006: Gynostemium micromorphology and pollination in Epipactis microphylla (Orchidaceae). Journal of Plant Research 119(5): 431-437
Chesneau, L.; Dupré, S.; Burdina, A.; Roger, Jérôme.; Le Panse, S.; Jacquet, M.; Cuif, M-Hélène. 2004: Gyp5p and Gyl1p are involved in the control of polarized exocytosis in budding yeast. Journal of Cell Science 117(Pt 20): 4757-4767
Huang, T.Hsun-Wei.; Li, Y.; Razmovski-Naumovski, V.; Tran, V.Hoan.; Li, G.Qian.; Duke, C.C.; Roufogalis, B.D. 2006: Gypenoside XLIX isolated from Gynostemma pentaphyllum inhibits nuclear factor-kappaB activation via a PPAR-alpha-dependent pathway. Journal of biomedical science 13(4): 535-548
Shang, L.; Liu, J.; Zhu, Q.; Zhao, L.; Feng, Y.; Wang, X.; Cao, W.; Xin, H. 2006: Gypenosides protect primary cultures of rat cortical cells against oxidative neurotoxicity. Brain Research 1102(1): 163-174
Mota, J.F.; Sola, A.J.; Jimenez Sanchez, M.L.; Perez Garcia, F.J.; Merlo, M.E. 2004: Gypsicolous flora, conservation and restoration of quarries in the southeast of the Iberian Peninsula. Biodiversity and Conservation 13(10): 1797-1808
Greimler, J.; Tremetsberger, K. 2001: Gypsophila fastigiata (Caryophyllaceae): in-situ- und ex-situ-Ma ss nahmen zur erhaltung einer in Osterreich vom Aussterben bedrohten Art. Neilreichia 1: 71-77
Babaoglu, M.; Gezgin, S.; Topal, A.; Sade, B.; Dural, H. 2004: Gypsophila sphaerocephala Fenzl ex Tchihat.: A boron hyperaccumulator plant species that may phytoremediate soils with toxic B levels. Turkish Journal of Botany 28(3): 273-278
Galdenzi, S.; Maruoka, T. 2003: Gypsum deposits in the Frasassi Caves, central Italy. Journal of Cave and Karst Studies 65(2): 111-125
Lebedeva, K.V.; Vendilo, N.V. 2003: Gypsy moth pheromones and their use for forest protection. Agrokhimiya 11: 61-70
Kosner, K. 2005: Gypsy women launch claim following sterilisation. BMJ 330(7486): 275
Johnson, E.P.; Yao, S.; Helinski, D.R. 2005: Gyrase inhibitors and thymine starvation disrupt the normal pattern of plasmid RK2 localization in Escherichia coli. Journal of Bacteriology 187(10): 3538-3547
Dobesberger, J.; Walser, G.; Embacher, N.; Unterberger, I.; Luef, G.; Bauer, G.; Benke, T.; Bartha, L.; Ortler, M.; Trinka, E. 2005: Gyratory seizures revisited: a video-EEG study. Neurology 64(11): 1884-1887
Booms, T.L.; Fuller, M.R. 2003: Gyrfalcon feeding behavior during the nestling period in central West Greenland. Arctic 56(4): 341-348
Harris, J.M.; Yates, S.; Miller, P.; Best, J.J.K.; Johnstone, E.C.; Lawrie, S.M. 2004: Gyrification in first-episode schizophrenia: a morphometric study. Biological Psychiatry 55(2): 141-147
Hatford, D.A. 2005: Gyrostemon osmus Halford (Gyrostemonaceae), a new species from south-eastern Queensland. Austrobaileya 7(1): 135-139
Goldberg, I.; Mogensen, G., S. 2005: Gyroweisia groenlandica (Kindb.) I. Goldberg & Mogensen, comb. nov for Weissia groenlandica Kindb. (Pottiaceae, Bryophyta). Lindbergia 30(1): 39-42
de Sio, M.; Autorino, R.; Quarto, G.; Damiano, R.; Perdonà, S.; di Lorenzo, G.; Mordente, S.; D'Armiento, M. 2006: Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial. Urology 67(1): 69-72
Yang, S.; Lin, W-Chou.; Chang, H-Kuang.; Hsu, J-Ming.; Lin, W-Rong.; Chow, Y-Chiong.; Tsai, W-Kung.; Lee, T-An.; Lo, K-Yik.; Chow, K.; Chen, M. 2004: Gyrus plasmasect: is it better than monopolar transurethral resection of prostate?. Urologia Internationalis 73(3): 258-261
Hewlett, B. 2005: H & E staining of cryostat sections. Biotechnic and Histochemistry 80(3-4): 170-171
Mégraud, F. 2004: H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53(9): 1374-1384
Kountouras, J.; Zavos, C.; Chatzopoulos, D. 2004: H pylori infection and reflux oesophagitis. Gut 53(6): 912
Makovec, M.; Benedicic, M.; Bosnjak, R. 2006: H wave and spinal root potentials in neuromonitoring of S1 root function during evacuation of herniated disc: preliminary results. Croatian Medical Journal 47(2): 298-304
Gordon, J.C.; Myers, J.B.; Folta, T.; Shoja, V.; Heath, L.S.; Onufriev, A. 2005: H++: a server for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids Research 33(Web Server Issue): W368-W371
Vallés, P.G.; Carrizo, L.; Seltzer, A.; Manucha, W. 2005: H-ATPase activity in collecting duct segments in protein-deprived rats - role of angiotensin II on its regulation. Nephron. Physiology 99(3): P90-100
Nakamura, S. 2006: H+-ATPase activity in selective disruption of H+-K+-ATPase alpha 1 gene of mice under normal and K-depleted conditions. Journal of Laboratory and Clinical Medicine 147(1): 45-51
Oliveira, P.F.; Lopes, I.A.; Barrias, C.; Rebelo da Costa, A.M. 2004: H+-ATPase of crude homogenate of the outer mantle epithelium of Anodonta cygnea. Comparative Biochemistry and Physiology. Part a Molecular and Integrative Physiology 139(4): 425-432
Itagaki, S.; Saito, Y.; Kubo, S.; Otsuka, Y.; Yamamoto, Y.; Kobayashi, M.; Hirano, T.; Iseki, K. 2004: H+-dependent transport mechanism of nateglinide in the brush-border membrane of the rat intestine. Journal of Pharmacology and Experimental Therapeutics 312(1): 77-82
Brambilla, P.; Stanley, J., A.; Nicoletti, M., A.; Sassi, R., B.; Mallinger, A., G.; Frank, E.; Kupfer, D., J.; Keshavan, M., S.; Soares, J., C. 2005: H-1 Magnetic prefrontal resonance spectroscopy study of dorsolateral cortex in unipolar mood disorder patients. Psychiatry Research Neuroimaging 138(2): 131-139
Constantinou, M., A.; Papakonstantinou, E.; Spraul, M.; Sevastiadou, S.; Costalos, C.; Koupparis, M., A.; Shulpis, K.; Tsantili-Kakoulidou, A.; Mikros, E. 2005: H-1 NMR-based metabonomics for the diagnosis of inborn errors of metabolism in urine. Analytica Chimica Acta 542(2): 169-177
Lockwood, J.M.; Wilkins, B.W.; Halliwill, J.R. 2005: H1 receptor-mediated vasodilatation contributes to postexercise hypotension. Journal of Physiology 563(Pt 2): 633-642
Cowley, A., B.; Urbauer, R., J.B.; Urbauer, J., L. 2005: H-1, C-13 and N-15 NMR assignments for AlgH, a putative transcritpional regulator from Pseudomonas aeruginosa. Journal of Biomolecular NMR 33(1): 74
Binbuga, B.; Young, J., K. 2005: H-1, C-13 and N-15 backbone and side chain resonance assignments of Haloferax volcanii DHFR1. Journal of Biomolecular NMR 33(4): 281
Sreeramulu, S.; Kumar, J.; Richter, C.; Vogtherr, M.; Saxena, K.; Langer, T.; Schwalbe, H. 2005: H-1, C-13 and N-15 backbone resonance assignment of the Hsp90 binding domain of human Cdc37. Journal of Biomolecular NMR 32(3): 262
Gao, T.; Zhang, X.; Xia, Y.; Cho, Y.; Sacchettini, J., C.; Golden, S., S.; Liwang, A., C. 2005: H-1, C-13 and N-15 chemical shift assignments of the C-terminal, 133-residue pseudo-receiver domain of circadian input kinase (CikA) in Synechococcus elongatus. Journal of Biomolecular NMR 32(3): 259
Petros, A., M.; Fesik, S., W.; Olejniczak, E., T. 2005: H-1, C-13 and N-15 resonance assignments of a Bcl-x(L)/bad peptide complex. Journal of Biomolecular NMR 32(3): 260
Kusunoki, H.; Hasegawa, T.; Komatsu, C.; Takeuchi, T.; Kohno, T. 2005: H-1, C-13 and N-15 resonance assignments of the AT-rich interaction domain (ARID) of Jumonji. Journal of Biomolecular NMR 33(1): 74
Yoshida, S.; Ogura, K.; Yokochi, M.; Yuzawa, S.; Horiuchi, M.; Morioka, H.; Sumimoto, H.; Inagaki, F. 2005: H-1, C-13 and N-15 resonance assignments of the backbone and methyl groups of the 24 kDa tetratricopeptide repeat domain in p67(phox). Journal of Biomolecular NMR 32(2): 176
Perry, A., J.; Hulett, J., M.; Lithgow, T.; Gooley, P., R. 2005: H-1, C-13 and N-15 resonance assignments of the cytosolic domain of Tom20 from Arabidopsis thaliana. Journal of Biomolecular NMR 33(3): 198
Markus, M., A.; Dwyer, B.; Wolfrom, S.; Li, J.; Li, W.; Malakian, K.; Wilhelm, J.; Tsao, D., H.H. 2005: H-1, C-13, and N-15 assignments of MMP-12, a key protease implicated in lung tissue remodeling. Journal of Biomolecular NMR 31(3): 260
Aramini, J., M.; Swapna, G.V.T.; Huang, Y., J.; Rajan, P.K.; Xiao, R.; Shastry, R.; Acton, T., B.; Cort, J., R.; Kennedy, M., A.; Montelione, G., T. 2005: H-1, C-13, and N-15 resonance assignments for Escherichia coli ytfP, a member of the broadly conserved UPF0131 protein domain family. Journal of Biomolecular NMR 33(3): 197
Rossi, P.; Ramelot, S.S.Theresa; Xiao, R.; Ho, C., K.; Ma, L.-Chung; Acton, T., B.; Kennedy, M., A.; Montelione, G., T. 2005: H-1, C-13, and N-15 resonance assignments for the protein coded by gene locus BB0938 of Bordetella bronchiseptica. Journal of Biomolecular NMR 33(3): 197
Mccallum, S., A.; Yin, J.; Fairbrother, W., J. 2005: H-1, C-13, and N-15 resonance assignments of SAP18. Journal of Biomolecular NMR 31(3): 259
Munte, C.-Elisabeth; Becker, K.; Schirmer, R.-Heiner; Kalbitzer, H.-Robert 2005: H-1, C-13, and N-15 sequence-specific resonance assignment and secondary structure of Plasmodium falciparum thioredoxin. Journal of Biomolecular NMR 32(4): 340
Lee, C.; Nancarrow, A., L.; Bach, I.; Mackay, J., P.; Matthews, J., M. 2005: H-1, N-15 and C-13 assignments of an intramolecular Lhx3 : ldb1 complex. Journal of Biomolecular NMR 33(3): 198
Chae, Y.-Kee; Lee, K.; Markley, J., L. 2005: H-1, N-15 and C-13 resonance assignments of a protein involved in the autophagy process, At4g21980.1 from Arabidopsis thaliana. Journal of Biomolecular NMR 32(4): 337
Wu, C.-Wei; Lin, Y.-Ting; Huang, K.-Chun; Cheng, J.-Wei 2005: H-1, N-15 and C-13 resonance assignments of the Domain III of the Dengue Virus Envelope Protein. Journal of Biomolecular NMR 33(1): 76
Dias, J., S.; Macedo, A., L.; Ferreira, G., C.; Jeanty, N.; Taketani, S.; Goodfellow, B., J.; Peterson, F., C.; Volkman, B., F. 2005: H-1, N-15 and C-13 resonance assignments of the heme-binding protein murine p22HBP. Journal of Biomolecular NMR 32(4): 338
Song, J.; Zhao, Q.; Lee, M., S.; Markley, J., L. 2005: H-1, N-15 and C-13 resonance assignments of the putative Bet v 1 family protein At1g24000.1 from Arabidopsis thaliana. Journal of Biomolecular NMR 32(4): 335
Lee, D.-Yeon; Rhee, S.-Goo; Ferretti, J.; Gruschus, J., M. 2005: H-1, N-15, and C-13 chemical shift assignments of the human Sulfiredoxin (hSrx). Journal of Biomolecular NMR 32(4): 339
Fry, D., C.; Emerson, S.D.; Liu, C.-Min; Palermo, R. 2005: H-1, N-15, and C-13 resonance assignments of human interleukin-2. Journal of Biomolecular NMR 32(3): 258
Ye, Y-lu.; Wang, M-ling.; Chen, L-ping.; Liu, L-ying.; Zhang, L-hui.; Chen, Z.; Wei, E-qing. 2006: H2 receptor mediates the protective effect of histamine against the cellular edema and viability reduction induced by oxygen-glucose deprivation in rat hippocampal slices. Yao Xue Xue Bao 41(4): 333-337
McCord, J.L.; Beasley, J.M.; Halliwill, J.R. 2005: H2-receptor-mediated vasodilation contributes to postexercise hypotension. Journal of Applied Physiology 100(1): 67-75
Menendez, A.; Pereiro, R.; Bordel, N.; Sanz-Medel, A. 2005: H-2/Ar direct current glow discharge mass spectrometry at constant voltage and pressure. Spectrochimica Acta Part B Atomic Spectroscopy 60(6): 824-833
Griffante, C.; Carletti, R.; Andreetta, F.; Corsi, M. 2006: H-3GR205171 displays similar NK1 receptor binding profile in gerbil and human brain. British Journal of Pharmacology 148(1): 39-45
Makaula, S.; Lochner, A.; Genade, S.; Sack, M.N.; Awan, M.M.; Opie, L.H. 2005: H-89, a non-specific inhibitor of protein kinase A, promotes post-ischemic cardiac contractile recovery and reduces infarct size. Journal of Cardiovascular Pharmacology 45(4): 341-347
Harting, I.; Jost, G.; Hacke, N.; Hartmann, M. 2005: H-Magnetresonanz spektroskopie von hirntumoren. Nervenarzt 76(4): 403-404,406-410,413-417
Tendeng, C.; Bertin, P.N. 2003: H-NS in Gram-negative bacteria: a family of multifaceted proteins. Trends in Microbiology 11(11): 511-518
Ono, S.; Goldberg, M.D.; Olsson, T.; Esposito, D.; Hinton, J.C.D.; Ladbury, J.E. 2005: H-NS is a part of a thermally controlled mechanism for bacterial gene regulation. Biochemical Journal 391(Pt 2): 203-213
Lucchini, S.; Rowley, G.; Goldberg, M.D.; Hurd, D.; Harrison, M.; Hinton, J.C.D. 2006: H-NS mediates the silencing of laterally acquired genes in bacteria. Plos Pathogens 2(8): E81
Ellison, D.W.; Miller, V.L. 2006: H-NS represses inv transcription in Yersinia enterocolitica through competition with RovA and interaction with YmoA. Journal of Bacteriology 188(14): 5101-5112
Meyer, A.; Morvan, F.; Vasseur, J.J.cques 2004: H-Phosphonate oligonucleotides from phosphoramidite chemistry. Tetrahedron Letters 45(19): 3745-3748
Carón, Rén.W.; Yacoub, A.; Zhu, X.; Mitchell, C.; Han, S.Iy.; Sasazuki, T.; Shirasawa, S.; Hagan, M.P.; Grant, S.; Dent, P. 2005: H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent. Molecular Cancer Therapeutics 4(2): 243-255
Nazarenko, I.; Kristiansen, G.; Fonfara, S.; Guenther, R.; Gieseler, C.; Kemmner, W.; Schafer, R.; Petersen, I.; Sers, C. 2006: H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling. American Journal of Pathology 169(4): 1427-1439
Zisoulis, D.G.; Kansas, G.S. 2004: H-Ras and phosphoinositide 3-kinase cooperate to induce alpha(1,3)-fucosyltransferase VII expression in Jurkat T cells. Journal of Biological Chemistry 279(38): 39495-39504
Pozzi, A.; Coffa, S.; Bulus, N.; Zhu, W.; Chen, D.; Chen, X.; Mernaugh, G.; Su, Y.; Cai, S.; Singh, A.; Brissova, M.; Zent, R. 2006: H-Ras, R-Ras, and TC21 differentially regulate ureteric bud cell branching morphogenesis. Molecular Biology of the Cell 17(4): 2046-2056
Petukhov, M.; Rychkov, G.; Firsov, L.; Serrano, L. 2004: H-bonding in protein hydration revisited. Protein Science: a Publication of the Protein Society 13(8): 2120-2129
Juranić, N.; Macura, S.; Prendergast, F.G. 2003: H-bonding mediates polarization of peptide groups in folded proteins. Protein Science: a Publication of the Protein Society 12(11): 2633-2636
Gu, J.; Wang, J.; Leszczynski, J. 2004: H-bonding patterns in the platinated guanine-cytosine base pair and guanine-cytosine-guanine-cytosine base tetrad: an electron density deformation analysis and AIM study. Journal of the American Chemical Society 126(39): 12651-12660
Hasani, M.; Yaghoubi, L.; Abdollahi, H. 2006: H-point standard addition method for simultaneous determination of Fe(II), Co(II) and Cu(II) in micellar media with simultaneous addition of three analytes. Talanta 68(5): 1528-1535
Afkhami, A.; Bahram, M. 2004: H-point standard addition method for simultaneous spectrophotometric determination of Co(II) and Ni(II) by 1-(2-pyridylazo)2-naphthol in micellar media. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy 60A(1-2): 181-186
Shams, E.; Abdollahi, H.; Yekehtaz, M.; Hajian, R. 2004: H-point standard addition method in the analysis by differential pulse anodic stripping voltammetry Simultaneous determination of lead and tin. Talanta 63(2): 359-364
Shiratsuchi, H.; Hirakawa, N.; Saito, T.; Oda, Y.; Yamamoto, H.; Tomita, K.; Yamamoto, T.; Tsuneyoshi, M. 2004: H-ras mutation is an additional event of sarcomatous transformation in aerodigestive spindle cell carcinoma. Oncology Reports 11(3): 597-604
Plowman, S.J.; Muncke, C.; Parton, R.G.; Hancock, J.F. 2005: H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proceedings of the National Academy of Sciences of the United States of America 102(43): 15500-15505
Shin, I.; Kim, S.; Song, H.; Kim, H.-R.C.; Moon, A. 2005: H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. Journal of Biological Chemistry 280(15): 14675-14683
Carp, J.S.; Tennissen, A.M.; Chen, X.Yang.; Wolpaw, J.R. 2006: H-reflex operant conditioning in mice. Journal of Neurophysiology 96(4): 1718-1727
Basran, J.; Harris, R.J.; Sutcliffe, M.J.; Scrutton, N.S. 2003: H-tunneling in the multiple H-transfers of the catalytic cycle of morphinone reductase and in the reductive half-reaction of the homologous pentaerythritol tetranitrate reductase. Journal of Biological Chemistry 278(45): 43973-43982
Pandolfino, J.E.; Howden, C.W.; Kahrilas, P.J. 2004: H. pylori and GERD: is less more?. American Journal of Gastroenterology 99(7): 1222-1225
Tanaka, S.; Mizuno, M.; Maga, T.; Yoshinaga, F.; Tomoda, J.; Nasu, J.; Okada, H.; Yokota, K.; Oguma, K.; Shiratori, Y.; Tsuji, T. 2003: H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase. Hepato-Gastroenterology 50(53): 1739-1742
Pulawski, E.; Mellwig, K.P.; Horstkotte, D. 2003: H.E.L.P.-Apherese und oxidativer Stress. Zeitschrift fuer Kardiologie 92(Suppl 3): 38-41
Mi, J.; Zhang, X.; Rabbani, Z.N.; Liu, Y.; Su, Z.; Vujaskovic, Z.; Kontos, C.D.; Sullenger, B.A.; Clary, B.M. 2006: H1 RNA polymerase IIi promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity. Nucleic Acids Research 34(12): 3577-3584
Ohtani, T.; Aiba, S.; Mizuashi, M.; Mollah, Z.U.A.; Nakagawa, S.; Tagami, H. 2003: H1 and H2 histamine receptors are absent on Langerhans cells and present on dermal dendritic cells. Journal of Investigative Dermatology 121(5): 1073-1079
Wong, B.J.; Wilkins, B.W.; Minson, C.T. 2004: H1 but not H2 histamine receptor activation contributes to the rise in skin blood flow during whole body heating in humans. Journal of Physiology 560(Pt 3): 941-948
Jangi, S.-M.; Díaz-Pérez, J.é L.ís.; Ochoa-Lizarralde, B.; Martín-Ruiz, I.; Asumendi, A.; Pérez-Yarza, G.; Gardeazabal, J.ús.; Díaz-Ramón, J.é L.; Boyano, M.ía.D. 2006: H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells. Carcinogenesis 27(9): 1787-1796
Giustizieri, M.L.; Albanesi, C.; Fluhr, J.; Gisondi, P.; Norgauer, J.; Girolomoni, G. 2004: H1 histamine receptor mediates inflammatory responses in human keratinocytes. Journal of Allergy and Clinical Immunology 114(5): 1176-1182
Smirnova, T.A.; Prusov, A.N.; Kolomijtseva, G.Ya.; Vanyushin, B.F. 2004: H1 histone in developing and aging coleoptiles of etiolated wheat seedlings. Biochemistry. Biokhimiia 69(10): 1128-1135
Galeotti, N.; Malmberg-Aiello, P.; Bartolini, A.; Schunack, W.; Ghelardini, C. 2004: H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. Neuropharmacology 47(2): 295-303
Hase, M.; Depre, C.; Vatner, S.F.; Sadoshima, J. 2005: H11 has dose-dependent and dual hypertrophic and proapoptotic functions in cardiac myocytes. Biochemical Journal 388(Part 2): 475-483
Depre, C.; Wang, L.; Sui, X.; Qiu, H.; Hong, C.; Hedhli, N.; Ginion, A.; Shah, A.; Pelat, M.; Bertrand, L.; Wagner, T.; Gaussin, V.; Vatner, S.F. 2006: H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart. Circulation Research 98(2): 280-288
Fellig, Y.; Ariel, I.; Ohana, P.; Schachter, P.; Sinelnikov, I.; Birman, T.; Ayesh, S.; Schneider, T.; de Groot, N.; Czerniak, A.; Hochberg, A. 2005: H19 expression in hepatic metastases from a range of human carcinomas. Journal of Clinical Pathology 58(10): 1064-1068
De Castro Valente Esteves, L.Isabel.; De Karla Cervigne, N.; Do Carmo Javaroni, A.; Magrin, Jé.; Kowalski, L.Paulo.; Rainho, Cáudia.Aparecida.; Rogatto, S.Regina. 2006: H19-DMR allele-specific methylation analysis reveals epigenetic heterogeneity of CTCF binding site 6 but not of site 5 in head-and-neck carcinomas: a pilot case-control analysis. International Journal of Molecular Medicine 17(2): 397-404
De-Matos-Gomes, M.-Vinicius; Dos-Santos, S.-Avelino; Silveira-Ramos, E. 2005: H19DMR methylation analysis in patients with Beckwith-Wiedemann syndrome and isolated hemihyperplasia. Genetics and Molecular Biology 28(2): 210-213
Van Ooteghem, S.A.; Jones, A.; Van Der Lelie, D.; Dong, B.; Mahajan, D. 2004: H(2) production and carbon utilization by Thermotoga neapolitana under anaerobic and microaerobic growth conditions. Biotechnology Letters 26(15): 1223-1232
Silvertown, J.D.; Ng, J.; Sato, T.; Summerlee, A.J.; Medin, J.A. 2006: H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis. International Journal of Cancer 118(1): 62-73
Du, M.; Irani, R.A.; Stivers, D.N.; Lee, S-Joon.; Travis, E.L. 2004: H2-Ea deficiency is a risk factor for bleomycin-induced lung fibrosis in mice. Cancer Research 64(19): 6835-6839
D'Orazio, S.E.F.; Shaw, C.A.; Starnbach, M.N. 2006: H2-M3-restricted CD8+ T cells are not required for MHC class Ib-restricted immunity against Listeria monocytogenes. Journal of Experimental Medicine 203(2): 383-391
Colmone, A.; Wang, C.-R. 2006: H2-M3-restricted T cell response to infection. Microbes and Infection 8(8): 2277-2283
Chow, M.T.; Dhanji, S.; Cross, J.; Johnson, P.; Teh, H-Sia. 2006: H2-M3-restricted T cells participate in the priming of antigen-specific CD4+ T cells. Journal of Immunology 177(8): 5098-5104
Chen, X.; Reed-Loisel, L.M.; Karlsson, L.; Jensen, P.E. 2006: H2-O expression in primary dendritic cells. Journal of Immunology 176(6): 3548-3556
Sleep, N.H.; Meibom, A.; Fridriksson, T.; Coleman, R.G.; Bird, D.K. 2004: H2-rich fluids from serpentinization: geochemical and biotic implications. Proceedings of the National Academy of Sciences of the United States of America 101(35): 12818-12823
Zhao, H.X.; Liu, X.M.; Chen, M-S. 2006: H22, a major resistance gene to the Hessian fly (Mayetiola destructor), is mapped to the distal region of wheat chromosome 1DS. Tag. Theoretical and Applied Genetics. Theoretische und Angewandte Genetik 113(8): 1491-1496
Valleix, S.; Nedelec, B.; Rigaudiere, F.; Dighiero, P.; Pouliquen, Y.; Renard, G.; Le Gargasson, J-François.; Delpech, M. 2006: H244R VSX1 is associated with selective cone ON bipolar cell dysfunction and macular degeneration in a PPCD family. Investigative Ophthalmology and Visual Science 47(1): 48-54
Fan, J.Y.; Rangasamy, D.; Luger, K.; Tremethick, D.J. 2004: H2A.Z alters the nucleosome surface to promote HP1alpha-mediated chromatin fiber folding. Molecular Cell 16(4): 655-661
Dhillon, N.; Oki, M.; Szyjka, S.J.; Aparicio, O.M.; Kamakaka, R.T. 2006: H2A.Z functions to regulate progression through the cell cycle. Molecular and Cellular Biology 26(2): 489-501
Sluss, H.K.; Davis, R.J. 2006: H2AX is a target of the JNK signaling pathway that is required for apoptotic DNA fragmentation. Molecular Cell 23(2): 152-153
Marti, T.M.; Hefner, E.; Feeney, L.; Natale, V.; Cleaver, J.E. 2006: H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks. Proceedings of the National Academy of Sciences of the United States of America 103(26): 9891-9896
Franco, S.; Gostissa, M.; Zha, S.; Lombard, D.B.; Murphy, M.M.; Zarrin, A.A.; Yan, C.; Tepsuporn, S.; Morales, J.C.; Adams, M.M.; Lou, Z.; Bassing, C.H.; Manis, J.P.; Chen, J.; Carpenter, P.B.; Alt, F.W. 2006: H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Molecular Cell 21(2): 201-214
Ingvarsdottir, K.; Krogan, N.J.; Emre, N.C.T.; Wyce, A.; Thompson, N.J.; Emili, A.; Hughes, T.R.; Greenblatt, J.F.; Berger, S.L. 2005: H2B ubiquitin protease Ubp8 and Sgf11 constitute a discrete functional module within the Saccharomyces cerevisiae SAGA complex. Molecular and Cellular Biology 25(3): 1162-1172
Osley, M.A. 2004: H2B ubiquitylation: the end is in sight. Biochimica et Biophysica Acta 1677(1-3): 74-78
Petersen, B.O.; Vinogradov, E.; Kay, W.; Würtz, P.; Nyberg, N.T.; Duus, J.Ø; Sørensen, O.W. 2006: H2BC: a new technique for NMR analysis of complex carbohydrates. Carbohydrate Research 341(4): 550-556
Demeny, A.; Vennemann, T., W.; Harangi, S.; Homonnay, Z.; Forizs, I. 2006: H2O-delta D-Fe-III relations of dehydrogenation and dehydration processes in magmatic amphiboles. Rapid Communications in Mass Spectrometry 20(5): 919-925
Shin, M.Hee.; Rhie, G-eun.; Kim, Y.Kyung.; Park, C-Hyun.; Cho, K.Hyun.; Kim, K.Han.; Eun, H.Chul.; Chung, J.Ho. 2005: H2O2 accumulation by catalase reduction changes MAP kinase signaling in aged human skin in vivo. Journal of Investigative Dermatology 125(2): 221-229
Colston, J.T.; de la Rosa, S.D.; Strader, J.R.; Anderson, M.A.; Freeman, G.L. 2005: H2O2 activates Nox4 through PLA2-dependent arachidonic acid production in adult cardiac fibroblasts. Febs Letters 579(11): 2533-2540
Gautam, D.K.; Misro, M.M.; Chaki, S.P.; Sehgal, N. 2005: H2O2 at physiological concentrations modulates Leydig cell function inducing oxidative stress and apoptosis. Apoptosis: An International Journal on Programmed Cell Death 11(1): 39-46
Zheng, Y.; Shen, X. 2005: H2O2 directly activates inositol 1,4,5-trisphosphate receptors in endothelial cells. Redox Report: Communications in Free Radical Research 10(1): 29-36
Vismara, C.; Bacchetta, R.; Di Muzio, A.; Mantecca, P.; Tarca, S.; Vailati, G.; Colombo, R. 2006: H2O2 induces abnormal tail flexure in Xenopus embryos: similarities with Paraquat teratogenic effects. Birth Defects Research. Part B Developmental and Reproductive Toxicology 77(3): 238-243
Fischer, S.; Wiesnet, M.; Renz, D.; Schaper, W. 2005: H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway. European Journal of Cell Biology 84(7): 687-697
Scott, M.D. 2006: H2O2 injury in beta thalassemic erythrocytes: protective role of catalase and the prooxidant effects of GSH. Free Radical Biology and Medicine 40(7): 1264-1272
González, A.; Granados, M.ía.P.; Pariente, J.é A.; Salido, G.és.M. 2006: H2O2 mobilizes Ca2+ from agonist- and thapsigargin-sensitive and insensitive intracellular stores and stimulates glutamate secretion in rat hippocampal astrocytes. Neurochemical Research 31(6): 741-750
Hudasek, K.; Brown, S.T.; Fearon, I.M. 2004: H2O2 regulates recombinant Ca2+ channel alpha1C subunits but does not mediate their sensitivity to acute hypoxia. Biochemical and Biophysical Research Communications 318(1): 135-141
Go, Y.--Mi; Gipp, J., J.; Mulcahy, R.T.; Jones, D., P. 2004: H2O2-dependent activation of GCLC-ARE4 reporter occurs by mitogen-activated protein kinase pathways without oxidation of cellular glutathione and thioredoxin-1. (vol 279, pg 5837, 2004). Journal of Biological Chemistry 279(15): 15706
Go, Y-Mi.; Gipp, J.J.; Mulcahy, R.Timothy.; Jones, D.P. 2004: H2O2-dependent activation of GCLC-ARE4 reporter occurs by mitogen-activated protein kinase pathways without oxidation of cellular glutathione or thioredoxin-1. Journal of Biological Chemistry 279(7): 5837-5845
González, A.; Granados, Mía.P.; Salido, Gés.M.; Pariente, Jé.A. 2005: H2O2-induced changes in mitochondrial activity in isolated mouse pancreatic acinar cells. Molecular and Cellular Biochemistry 269(1-2): 165-173
Tatsuishi, T.; Iwase, K.; Nishimura, Y.; Nakao, H.; Umebayashi, C.; Ueha Ishibashi, T.; Oyama, Y.; Boldyrev, A. 2004: H2O2-induced death of rat thymocytes is delayed by thimerosal, a preservative in vaccines. Biologicheskie Membrany 21(4): 306-309
Samuilov, V.D.; Timofeev, K.N.; Sinitsyn, S.V.; Bezryadnov, D.V. 2004: H2O2-induced inhibition of photosynthetic O2 evolution by Anabaena variabilis cells. Biochemistry. Biokhimiia 69(8): 926-933
Van der Wijk, T.; Overvoorde, J.; den Hertog, J. 2004: H2O2-induced intermolecular disulfide bond formation between receptor protein-tyrosine phosphatases. Journal of Biological Chemistry 279(43): 44355-44361
Mehdi, M.Z.; Pandey, N.R.; Pandey, S.K.; Srivastava, A.K. 2005: H2O2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src. Antioxidants and Redox Signaling 7(7-8): 1014-1020
Loiko, E.N.; Samal, A.B.; Shulyakovskaya, S.M. 2003: H2O2-induced platelet aggregation and increase in intracellular Ca2+ concentration are blocked by inhibitors of intracellular signaling. Biochemistry. Biokhimiia 68(11): 1210-1216
Rogers, P.A.; Dick, G.M.; Knudson, J.D.; Focardi, M.; Bratz, I.N.; Swafford, A.N.; Saitoh, S-Ichi.; Tune, J.D.; Chilian, W.M. 2006: H2O2-induced redox-sensitive coronary vasodilation is mediated by 4-aminopyridine-sensitive K+ channels. American Journal of Physiology. Heart and Circulatory Physiology 291(5): H2473-H2482
Cao, W.; Harnett, K.M.; Cheng, L.; Kirber, M.T.; Behar, J.; Biancani, P. 2005: H(2)O(2): a mediator of esophagitis-induced damage to calcium-release mechanisms in cat lower esophageal sphincter. American Journal of Physiology. Gastrointestinal and Liver Physiology 288(6): G1170-G1178
Eghbal, M.A.; Pennefather, P.S.; O'Brien, P.J. 2004: H2S cytotoxicity mechanism involves reactive oxygen species formation and mitochondrial depolarisation. Toxicology 203(1-3): 69-76
Son, H.-Jin; Lee, J.-Heon 2005: H2S removal with an immobilized cell hybrid reactor. Process Biochemistry 40(6): 2197-2203
Kamoun, P. 2004: H2S, un nouveau neuromodulateur. M S (Medecine Sciences) 20(6-7): 697-700
Torrent, A.; Moreno-Delgado, D.; Gómez-Ramírez, J.; Rodríguez-Agudo, D.; Rodríguez-Caso, C.; Sánchez-Jiménez, F.; Blanco, I.; Ortiz, Jí. 2004: H3 autoreceptors modulate histamine synthesis through calcium/calmodulin- and cAMP-dependent protein kinase pathways. Molecular Pharmacology 67(1): 195-203
Cui, N.; Kang, Y.; He, Y.; Leung, Y-Man.; Xie, H.; Pasyk, E.A.; Gao, X.; Sheu, L.; Hansen, J.B.; Wahl, P.; Tsushima, R.G.; Gaisano, H.Y. 2004: H3 domain of syntaxin 1A inhibits KATP channels by its actions on the sulfonylurea receptor 1 nucleotide-binding folds-1 and -2. Journal of Biological Chemistry 279(51): 53259-53265
Ebbs, M.L.; Bartee, L.; Bender, J. 2005: H3 lysine 9 methylation is maintained on a transcribed inverted repeat by combined action of SUVH6 and SUVH4 methyltransferases. Molecular and Cellular Biology 25(23): 10507-10515
Orchel, J.; Slowinski, J.; Mazurek, U.; Wilczok, T. 2004: H3 mRNA level as a new proliferative marker in astrocytomas. Biochimica et Biophysica Acta 1689(1): 42-46
Mishra, B.-Gopal; Kumar, D.; Rao, V.S. 2006: H3PW12O40 catalyzed expeditious synthesis of 3,4-dihydropyrimidin-2(1H)-ones under solvent-free conditions. Catalysis Communications 7(7): 457-459
Boltz, D.A.; Douangngeun, B.; Sinthasak, S.; Phommachanh, P.; Rolston, S.; Chen, H.; Guan, Y.; Peiris, J.S.Malik.; Smith, J.Gavin.J.D.; Webster, R.G. 2006: H5N1 influenza viruses in Lao People's Democratic Republic. Emerging Infectious Diseases 12(10): 1593-1595
Guan, Y.; Poon, L.L.M.; Cheung, C.Y.; Ellis, T.M.; Lim, W.; Lipatov, A.S.; Chan, K.H.; Sturm-Ramirez, K.M.; Cheung, C.L.; Leung, Y.H.C.; Yuen, K.Y.; Webster, R.G.; Peiris, J.S.M. 2004: H5N1 influenza: a protean pandemic threat. Proceedings of the National Academy of Sciences of the United States of America 101(21): 8156-8161
Flanagan, M.L.; Khawli, L.A.; Hu, P.; Epstein, A.L. 2006: H60/TNT-3 fusion protein activates NK cells in vitro and improves immunotherapeutic outcome in murine syngeneic tumor models. Journal of ImmunoTherapy 29(3): 274-283
Lindmark, F.; Zheng, S.L.; Wiklund, F.; Bensen, J.; Bälter, K.A.; Chang, B.; Hedelin, M.; Clark, J.; Stattin, P.är.; Meyers, D.A.; Adami, H.-O.; Isaacs, W.; Grönberg, H.; Xu, J. 2004: H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. Journal of the National Cancer Institute 96(16): 1248-1254
Skommer, J.; Wlodkowic, D.; Mättö, M.; Eray, M.; Pelkonen, J. 2006: HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells. Leukemia Research 30(3): 322-331
Tung, H.-Hsin; Unz, R., F.; Xie, Y., F. 2006: HAA removal by GAC adsorption. Journal - American Water Works Association 98(6): 107-112
Verma, S. 2006: HAART attenuates liver fibrosis in patients with HIV/HCV co-infection: fact or fiction?. Journal of Antimicrobial ChemoTherapy 58(3): 496-501
Cabello, A.; Rivero, A.; Garcia, M.á J.é; Lozano, J.é M.; Torre-Cisneros, J.; González, R.; Dueñas, G.; Galiani, M.D.; Camacho, A.; Santamaria, M.; Solana, R.; Montero, C.; Kindelán, J.é M.á; Peña, J.é 2003: HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals. Human Immunology 64(11): 1045-1049
Roca, B.; Lapuebla, C.; Vidal-Tegedor, B. 2005: HAART with didanosine once versus twice daily: adherence and efficacy. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 9(4): 195-200
Horster, S.; Goebel, F.D. 2004: HAART-prolonged life of HIV-infected patients should not be shortened by hepatitis C. Infection 32(6): 369-371
Daugas, E.; Rougier, J.-P.; Hill, G. 2005: HAART-related nephropathies in HIV-infected patients. Kidney International 67(2): 393-403
Mallick, J.; Datta, K. 2005: HABP1/p32/gC1qR induces aberrant growth and morphology in Schizosaccharomyces pombe through its N-terminal alpha helix. Experimental Cell Research 309(2): 250-263
Mitrovic, R.; Klajic, R.; Vicentijevic, M. 2005: HACCP Sistem U Radijaciono-Higijenskom Nadzoru Svinjarske Proizvodnje. Veterinarski Glasnik 59(5-6): 529-547
Adams, D.J.; Beveridge, D.J.; van der Weyden, L.; Mangs, H.; Leedman, P.J.; Morris, B.J. 2003: HADHB, HuR, and CP1 bind to the distal 3'-untranslated region of human renin mRNA and differentially modulate renin expression. Journal of Biological Chemistry 278(45): 44894-44903
Kalmár, L.; Hegedüs, T.ás.; Farkas, H.; Nagy, M.; Tordai, A. 2005: HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene. Human Mutation 25(1): 1-5
De Magalhães, J.ão.P.; Costa, J.; Toussaint, O. 2005: HAGR: the Human Ageing Genomic Resources. Nucleic Acids Research 33(Database Issue): D537-D543
Oberst, M.D.; Chen, L-Yuan.L.; Kiyomiya, K-Ichi.; Williams, C.A.; Lee, M-Shyue.; Johnson, M.D.; Dickson, R.B.; Lin, C-Yong. 2005: HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. American Journal of Physiology. Cell Physiology 289(2): C462-C470
Pichini, S.; Ventura, M.; Pujadas, M.; Ventura, R.; Pellegrini, M.; Zuccaro, P.; Pacifici, R.; de la Torre, R. 2004: HAIRVEQ: an external quality control scheme for drugs of abuse analysis in hair. Forensic Science International 145(2-3): 109-115
Stifelman, M.; Patel, R. 2004: HALS devices and operating room set-up: pearls and pitfalls. Journal of Endourology 18(4): 315-318
Düringer, C.; Hamiche, A.; Gustafsson, L.; Kimura, H.; Svanborg, C. 2003: HAMLET interacts with histones and chromatin in tumor cell nuclei. Journal of Biological Chemistry 278(43): 42131-42135
Hallgren, O.; Gustafsson, L.; Irjala, H.; Selivanova, G.; Orrenius, S.; Svanborg, C. 2006: HAMLET triggers apoptosis but tumor cell death is independent of caspases, Bcl-2 and p53. Apoptosis: An International Journal on Programmed Cell Death 11(2): 221-233
Jacolot, S.; Le Gac, G.; Scotet, V.; Quere, I.; Mura, C.; Ferec, C. 2004: HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Blood 103(7): 2835-2840
Morita, K.; Lo Celso, C.; Spencer-Dene, B.; Zouboulis, C.C.; Watt, F.M. 2006: HAN11 binds mDia1 and controls GLI1 transcriptional activity. Journal of Dermatological Science 44(1): 11-20
Li, X.-J.; Li, S.-H. 2005: HAP1 and intracellular trafficking. Trends in Pharmacological Sciences 26(1): 1-3
Zhang, K.; Sun, F.; Zhao, H. 2005: HAPLORE: a program for haplotype reconstruction in general pedigrees without recombination. Bioinformatics 21(1): 90-103
Gu, S.; Pakstis, A.J.; Kidd, K.K. 2005: HAPLOT: a graphical comparison of haplotype blocks, tagSNP sets and SNP variation for multiple populations. Bioinformatics 21(20): 3938-3939
Tofuku, K.; Yokouchi, M.; Murayama, T.; Minami, S.; Komiya, S. 2006: HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells. International Journal of Oncology 29(1): 175-183
Pugh, B.Franklin. 2006: HATs off to PIC assembly. Molecular Cell 23(6): 776-777
Cheon, K.Woo.; Baek, K-Hyun. 2006: HAUSP as a therapeutic target for hematopoietic tumors (review). International Journal of Oncology 28(5): 1209-1215
Lee, H.-J.; Kim, M.-S.; Kim, Y.-K.; Oh, Y.-K.; Baek, K.-H. 2005: HAUSP, a deubiquitinating enzyme for p53, is polyubiquitinated, polyneddylated, and dimerized. Febs Letters 579(21): 4867-4872
Holowaty, M.N.; Frappier, L. 2004: HAUSP/USP7 as an Epstein-Barr virus target. Biochemical Society Transactions 32(Pt 5): 731-732
Shaw, J.; Kirshenbaum, L.A. 2006: HAX-1 represses postmitochondrial caspase-9 activation and cell death during hypoxia-reoxygenation. Circulation Research 99(4): 336-338
Huang, Y.; Jiang, J.; Dou, K.; Chen, Z. 2005: HAb18G/CD147 enhances the secretion of matrix metalloproteinases (MMP) via cGMP/NO-sensitive capacitative calcium entry (CCE) and accordingly attenuates adhesion ability of fibroblasts. European Journal of Cell Biology 84(1): 59-73
Jiang, J.L.; Chan, H.C.; Zhou, Q.; Yu, M.K.; Yao, X.Y.; Lam, S.Y.; Zhu, H.; Ho, L.S.; Leung, K.M.; Chen, Z.N. 2004: HAb18G/CD147-mediated calcium mobilization and hepatoma metastasis require both C-terminal and N-terminal domains. Cellular and Molecular Life Sciences: Cmls 61(16): 2083-2091
Tagwerker, C.; Zhang, H.; Wang, X.; Larsen, L.S.Z.; Lathrop, R.H.; Hatfield, G.W.; Auer, B.; Huang, L.; Kaiser, P. 2006: HB tag modules for PCR-based gene tagging and tandem affinity purification in Saccharomyces cerevisiae. Yeast 23(8): 623-632
Jiang, H-Jie.; Sun, H-Shan.; Wang, X-Dong.; Wang, C-Liu.; Liu, Z-Long.; Gonda, H.; Sugimoto, K. 2006: HB-1, an acute myeloid leukemic cell line with the capability of infiltrating into the brain in CBA/N mice. Sheng Li Xue Bao: 58(4): 377-383
Lee, P.H.A.; Rudisill, J.A.; Lin, K.H.; Zhang, L.; Harris, S.M.; Falla, T.J.; Gallo, R.L. 2004: HB-107, a nonbacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair. Wound Repair and Regeneration: Official Publication of the Wound Healing Society and the European Tissue Repair Society 12(3): 351-358
El-Assal, O.N.; Besner, G.E. 2005: HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology 129(2): 609-625
Ongusaha, P.P.; Kwak, J.C.; Zwible, A.J.; Macip, S.; Higashiyama, S.; Taniguchi, N.; Fang, L.; Lee, S.W. 2004: HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Research 64(15): 5283-5290
Mine, N.; Iwamoto, R.; Mekada, E. 2005: HB-EGF promotes epithelial cell migration in eyelid development. Development 132(19): 4317-4326
Krampera, M.; Pasini, A.; Rigo, A.; Scupoli, M.Teresa.; Tecchio, C.; Malpeli, G.; Scarpa, A.; Dazzi, F.; Pizzolo, G.; Vinante, F. 2005: HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood 106(1): 59-66
Weuste, M.; Wurm, A.; Iandiev, I.; Wiedemann, P.; Reichenbach, A.; Bringmann, A. 2006: HB-EGF: increase in the ischemic rat retina and inhibition of osmotic glial cell swelling. Biochemical and Biophysical Research Communications 347(1): 310-318
Hienola, A.; Pekkanen, M.; Raulo, E.; Vanttola, P.äi.; Rauvala, H. 2004: HB-GAM inhibits proliferation and enhances differentiation of neural stem cells. Molecular and Cellular Neurosciences 26(1): 75-88
Aston, J.A.D.; Turkheimer, F.E.; Brett, M. 2006: HBM functional imaging analysis contest data analysis in wavelet space. Human Brain Mapping 27(5): 372-379
Liu, J.; Yang, J.; Liao, S. 2004: HBME-1 CD15 and p53 protein expression in thyroid carcinoma and their significance in diagnosis. Chinese Journal of Clinical Oncology 31(1): 37-41
Ito, Y.; Yoshida, H.; Tomoda, C.; Miya, A.; Kobayashi, K.; Matsuzuka, F.; Kakudo, K.; Kuma, K.; Miyauchi, A. 2005: HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma. Anticancer Research 25(1a): 179-182
Gunasekera, A.S.; Sfanos, K.S.; Harmody, D.K.; Pomponi, S.A.; McCarthy, P.J.; Lopez, J.V. 2005: HBMMD: an enhanced database of the microorganisms associated with deeper water marine invertebrates. Applied Microbiology and Biotechnology 66(4): 373-376
Berasi, S.P.; Xiu, M.; Yee, A.S.; Paulson, K.E. 2004: HBP1 repression of the p47phox gene: cell cycle regulation via the NADPH oxidase. Molecular and Cellular Biology 24(7): 3011-3024
Tamori, A.; Nishiguchi, S.; Kubo, S.; Narimatsu, T.; Habu, D.; Takeda, T.; Hirohashi, K.; Shiomi, S. 2003: HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. Journal of Medical Virology 71(4): 492-498
Gao, Y.; Jiang, Q.; Zhou, X.; Ding, B.; Wang, R.; Zhao, G.; Chen, Y. 2004: HBV infection and familial aggregation of liver cancer: an analysis of case-control family study. Cancer Causes and Control: Ccc 15(8): 845-850
Sarrecchia, C.; Cappelli, A.; Aiello, P. 2005: HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of ChemoTherapy 11(4): 189-191
Pereira, J.S.F.; Gonçales, N.S.L.; Silva, C.; Lazarini, M.S.K.; Pavan, M.H.P.; Fais, V.C.; Gonçales Júnior, F.L. 2006: HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors. Brazilian Journal of Medical and Biological Research 39(4): 525-531
Hatzakis, A.; Magiorkinis, E.; Haida, C. 2006: HBV virological assessment. Journal of Hepatology 44(1 Suppl): S71-S76
Comar, M.; Dal Molin, G.; D'Agaro, P.; Crocè, S.L.; Tiribelli, C.; Campello, C. 2006: HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers. Journal of Clinical Pathology 59(5): 526-529
Fujii, R.; Zhu, C.; Wen, Y.; Marusawa, H.; Bailly-Maitre, B.; Matsuzawa, S.-i.; Zhang, H.; Kim, Y.; Bennett, C.F.; Jiang, W.; Reed, J.C. 2006: HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Research 66(18): 9099-9107
Thébault, S.; Basbous, J.; Hivin, P.; Devaux, C.; Mesnard, J.-M. 2004: HBZ interacts with JunD and stimulates its transcriptional activity. Febs Letters 562(1-3): 165-170
Wang, Y.; Cui, F.; Lv, Y.; Li, C.; Xu, X.; Deng, C.; Wang, D.; Sun, Y.; Hu, G.; Lang, Z.; Huang, C.; Yang, X. 2004: HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology 39(2): 318-324
Ridruejo, E.; Brunet, Mía.del.Rosario.; Cusumano, A.; Diaz, C.; Michel, M.Davalos.; Jost, L.; Jost, L.; Mando, O.G.; Vilches, A. 2004: HBsAg as predictor of outcome in renal transplant patients. Medicina 64(5): 429-432
Louisirirotchanakul, S.; Kanoksinsombat, C.; O'Charoen, R.; Fongsatikul, L.; Puapairoj, C.; Lulitanond, V.; Appassakij, H.; Promwong, C.; Wasi, C. 2006: HBsAg diagnostic kits in the detection of hepatitis B virus mutation within "a" determinant. Viral Immunology 19(1): 108-114
Yuen, M.-F.; Wong, D.K.-H.; Sablon, E.; Tse, E.; Ng, I.O.-L.; Yuan, H.-J.; Siu, C.-W.; Sander, T.J.; Bourne, E.J.; Hall, J.G.; Condreay, L.D.; Lai, C.-L. 2004: HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology 39(6): 1694-1701
Shao-Xian-An; Xu-Wei; Wang-Ying; Xiong-Si-Dong 2004: HBsAg-like protein detected in the bovine serum. Fudan Xuebao 31(6): 585-587, 596
Zhang, S.M.; Sun, D.C.; Lou, S.; Bo, X.C.; Lu, Z.; Qian, X.H.; Wang, S.Q. 2005: HBx protein of hepatitis B virus (HBV) can form complex with mitochondrial HSP60 and HSP70. Archives of Virology 150(8): 1579-1590
Walton, J.D. 2006: HC-toxin. Phytochemistry 67(14): 1406-1413
Nagano, C.S.; Debray, H.; Nascimento, K.S.; Pinto, V.P.T.; Cavada, B.S.; Saker-Sampaio, S.; Farias, W.R.L.; Sampaio, A.H.; Calvete, J.J. 2005: HCA and HML isolated from the red marine algae Hypnea cervicornis and Hypnea musciformis define a novel lectin family. Protein Science: a Publication of the Protein Society 14(8): 2167-2176
Hoffmann, R.; Dopazo, J.; Cigudosa, J.C.; Valencia, A. 2005: HCAD, closing the gap between breakpoints and genes. Nucleic Acids Research 33(Database Issue): D511-D513
Cooper, D.A. 2005: HCB, PCB, PCDD and PCDF emissions from ships. Atmospheric Environment 39(27): 4901-4912
Shin, S.M.; Chung, Y.J.; Oh, S.T.; Jeon, H.M.; Hwang, L.J.; Namkoong, H.; Kim, H.K.; Cho, G.W.; Hur, S.Y.; Kim, T.E.; Lee, Y.S.; Park, Y.G.; Ko, J.; Kim, J.W. 2006: HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis. Gastroenterology 130(7): 2074-2086
Luciano, R.L.; Wilson, A.C. 2003: HCF-1 functions as a coactivator for the zinc finger protein Krox20. Journal of Biological Chemistry 278(51): 51116-51124
Zygmunt, M.; McKinnon, T.; Herr, F.; Lala, P.K.; Han, V.K.M. 2005: HCG increases trophoblast migration in vitro via the insulin-like growth factor-II/mannose-6 phosphate receptor. Molecular Human Reproduction 11(4): 261-267
Kumazawa, Y.; Kawamura, K.; Sato, T.; Sato, N.; Konishi, Y.; Shimizu, Y.; Shimizu, Y.; Fukuda, J.; Kodama, H.; Kodoma, H.; Tanaka, T. 2005: HCG up-regulates survivin mRNA in human granulosa cells. Molecular Human Reproduction 11(3): 161-166
Falcón, M.; Oliva, J.; Osuna, E.; Barba, A.; Luna, A. 2004: HCH and DDT residues in human placentas in Murcia (Spain). Toxicology 195(2-3): 203-208
Liu, M.; Yang, Y.; Xu, S.; Liu, H.; Hou, L.; Ou, D.; Liu, Q.; Cheng, S. 2006: HCHs and DDTs in salt marsh plants (Scirpus) from the Yangtze estuary and nearby coastal areas, China. Chemosphere 62(3): 440-448
Yang, Y.; Liu, M.; Xu, S.; Hou, L.; Ou, D.; Liu, H.; Cheng, S.; Hofmann, T. 2006: HCHs and DDTs in sediment-dwelling animals from the Yangtze Estuary, China. Chemosphere 62(3): 381-389
Sun, L.; Zhu, R.; Liu, X.; Xie, Z.; Yin, X.; Zhao, S.; Wang, Y. 2005: HCI-soluble Sr-87/Sr-86 ratio in sediments impacted by penguin or seal excreta as a proxy for historical population size in the maritime Antarctic. Marine Ecology Progress Series 303: 43-50
Morerio, C.; Acquila, M.; Rosanda, C.; Rapella, A.; Dufour, C.; Locatelli, F.; Maserati, E.; Pasquali, F.; Panarello, C. 2004: HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2). Cancer Research 64(8): 2649-2651
Smith, M.Shane.; Bentz, G.L.; Smith, P.M.; Bivins, E.R.; Yurochko, A.D. 2004: HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner. Journal of Leukocyte Biology 76(1): 65-76
Konopka, W.; Duniec, K.; Mioduszewska, B.; Proszynski, T.; Jaworski, J.; Kaczmarek, L. 2005: HCMV and Tet promoters for inducible gene expression in rat neurons in vitro and in vivo. Neurobiology of Disease 19(1-2): 283-292
Wang, J.; Shen, Y.H.; Utama, B.; Wang, J.; LeMaire, S.A.; Coselli, J.S.; Vercellotti, G.M.; Wang, X.L. 2006: HCMV infection attenuates hydrogen peroxide induced endothelial apoptosis-- involvement of ERK pathway. Febs Letters 580(11): 2779-2787
Reinhardt, B.; Mertens, T.; Mayr-Beyrle, U.; Frank, H.; Lüske, A.; Schierling, K.; Waltenberger, J. 2005: HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF beta-receptor. Cardiovascular Research 67(1): 151-160
Vischer, H.F.; Leurs, R.; Smit, M.J. 2006: HCMV-encoded G-protein-coupled receptors as constitutively active modulators of cellular signaling networks. Trends in Pharmacological Sciences 27(1): 56-63
Droese, J.; Mokros, T.; Hermosilla, R.; Schülein, R.; Lipp, M.; Höpken, U.E.; Rehm, A. 2004: HCMV-encoded chemokine receptor US28 employs multiple routes for internalization. Biochemical and Biophysical Research Communications 322(1): 42-49
Irvine, W.M.; Bergman, P.; Lowe, T.B.; Matthews, H.; McGonagle, D.; Nummelin, A.; Owen, T. 2003: HCN and HNC in comets C/2000 WM1 (Linear) and C/2002 C1 (Ikeya-Zhang). Origins of Life and Evolution of the Biosphere: the Journal of the International Society for the Study of the Origin of Life 33(6): 609-619
Chen, X.; Sirois, J.E.; Lei, Q.; Talley, E.M.; Lynch, C.; Bayliss, D.A. 2005: HCN subunit-specific and cAMP-modulated effects of anesthetics on neuronal pacemaker currents. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 25(24): 5803-5814
Milligan, C.J.; Edwards, I.J.; Deuchars, J. 2006: HCN1 ion channel immunoreactivity in spinal cord and medulla oblongata. Brain Research 1081(1): 79-91
Chan, C.S.; Shigemoto, R.; Mercer, J.N.; Surmeier, D.J. 2004: HCN2 and HCN1 channels govern the regularity of autonomous pacemaking and synaptic resetting in globus pallidus neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 24(44): 9921-9932
Hong, S-Eui.; Rho, S-Hwan.; Yeom, Y.Il.; Kim, D.Han. 2006: HCNet: a database of heart and calcium functional network. Bioinformatics 22(16): 2053-2054
Abdulnour-Nakhoul, S.; Nakhoul, N.L.; Wheeler, S.A.; Wang, P.; Swenson, E.R.; Orlando, R.C. 2004: HCO3- secretion in the esophageal submucosal glands. American Journal of Physiology. Gastrointestinal and Liver Physiology 288(4): G736-G744
Wright, M.W.; Eyre, T.A.; Lush, M.J.; Povey, S.; Bruford, E.A. 2005: HCOP: the HGNC comparison of orthology predictions search tool. Mammalian Genome: Official Journal of the International Mammalian Genome Society 16(11): 827-828
Suomela, S.; Elomaa, O.; Asumalahti, K.; Kariniemi, A.L.; Karvonen, S.L.; Peltonen, J.; Kere, J.; Saarialho-Kere, U. 2003: HCR, a candidate gene for psoriasis, is expressed differently in psoriasis and other hyperproliferative skin disorders and is downregulated by interferon-gamma in keratinocytes. Journal of Investigative Dermatology 121(6): 1360-1364
Xu, Z.; Liang, L.; Wang, H.; Li, T.; Zhao, M. 2003: HCRP1, a novel gene that is downregulated in hepatocellular carcinoma, encodes a growth-inhibitory protein. Biochemical and Biophysical Research Communications 311(4): 1057-1066
Chiou, H-Ling.; Hsieh, Y-Shou.; Hsieh, M-Ru.; Chen, T-Yen. 2006: HCV E2 may induce apoptosis of Huh-7 cells via a mitochondrial-related caspase pathway. Biochemical and Biophysical Research Communications 345(1): 453-458
Yannopoulos, C.G.; Xu, P.; Ni, F.; Chan, L.; Pereira, O.Z.; Reddy, T.J.; Das, S.K.; Poisson, C.; Nguyen-Ba, N.; Turcotte, N.; Proulx, M.; Halab, L.; Wang, W.; Bédard, J.; Morin, N.; Hamel, M.; Nicolas, O.; Bilimoria, D.; L'Heureux, L.; Bethell, R.; Dionne, G. 2004: HCV NS5B polymerase-bound conformation of a soluble sulfonamide inhibitor by 2D transferred NOESY. Bioorganic and Medicinal Chemistry Letters 14(21): 5333-5337
Summa, V.; Petrocchi, A.; Matassa, V.G.; Taliani, M.; Laufer, R.; De Francesco, R.; Altamura, S.; Pace, P. 2004: HCV NS5b RNA-dependent RNA polymerase inhibitors: from alpha,gamma-diketoacids to 4,5-dihydroxypyrimidine- or 3-methyl-5-hydroxypyrimidinonecarboxylic acids. Design and synthesis. Journal of Medicinal Chemistry 47(22): 5336-5339
Morishima, C.; Morgan, T.R.; Everhart, J.E.; Wright, E.C.; Shiffman, M.L.; Everson, G.T.; Lindsay, K.L.; Lok, A.S.F.; Bonkovsky, H.L.; Di Bisceglie, A.M.; Lee, W.M.; Dienstag, J.L.; Ghany, M.G.; Gretch, D.R. 2006: HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial. Hepatology 44(2): 360-367
Keresztes, K.; Takács, Mária.; Horányi, M.; Miltényi, Zófia.; Illés, Aád. 2003: HCV and HGV infection in Hodgkin's disease. Pathology Oncology Research: Por 9(4): 222-225
Simpore, J.; Ilboudo, D.; Samandoulougou, A.; Guardo, P.; Castronovo, P.; Musumeci, S. 2005: HCV and HIV co-infection in pregnant women attending St. Camille Medical Centre in Ouagadougou (Burkina Faso). Journal of Medical Virology 75(2): 209-212
Tomei, L.; Altamura, S.; Paonessa, G.; De Francesco, R.; Migliaccio, G. 2005: HCV antiviral resistance: the impact of in vitro studies on the development of antiviral agents targeting the viral NS5B polymerase. Antiviral Chemistry and ChemoTherapy 16(4): 225-245
Sabry, A.; E-Agroudy, A.; Sheashaa, H.; El-Husseini, A.; Mohamed Taha, N.; Elbaz, M.; Sobh, M. 2005: HCV associated glomerulopathy in Egyptian patients: clinicopathological analysis. Virology 334(1): 10-16
Moreno, A.; Bárcena, R.; García-Garzón, S.; Muriel, A.; Quereda, C.; Moreno, L.; Mateos, Mía.L.; Fortún, Jús.; Martín-Dávila, P.; García, M.; Blesa, C.; Otón, E.; Moreno, A.; Moreno, S. 2005: HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin. Journal of Hepatology 43(5): 783-790
Diz Dios, P.; Castro, A.; Rodríguez, I.; Reforma, N.G.; Castro, M.; Eirea, M.; Hermida, M. 2005: HCV clearance patterns in saliva and serum of patients with chronic HCV infection under interferon plus ribavirin therapy. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 34(5): 308-311
Kimball, P.; Verbeke, S.; Shiffman, M. 2005: HCV core protein augments cyclosporine immunosuppression. Transplantation Proceedings 37(2): 652-653
Aguilar, J.C.; Acosta-Rivero, N.; Dueñas-Carrera, S.; Morales Grillo, J.; Pichardo, D.; Urquiza, D.; Guillen, G.; Muzio, V. 2003: HCV core protein modulates the immune response against the HBV surface antigen in mice. Biochemical and Biophysical Research Communications 310(1): 59-63
Shin, J.-Yeop; Hur, W.; Wang, J.-Sang; Jang, J.-Won; Kim, C.-Wook; Bae, S.-Hyun; Jang, S.-Key; Yang, S.-Hwan; Sung, Y.-Chul; Kwon, O.-Joo; Yoon, S.-Kew 2005: HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta 1. Experimental and Molecular Medicine 37(2): 138-145
Acosta-Rivero, N.; Dueñas-Carrera, S.; Alvarez-Lajonchere, L.; Morales-Grillo, J. 2004: HCV core protein-expressing DNA vaccine induces a strong class I-binding peptide DTH response in mice. Biochemical and Biophysical Research Communications 314(3): 781-786
Siavoshian, S.; Abraham, J.D.; Kieny, M.P.; Schuster, C. 2004: HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines. Archives of Virology 149(2): 323-336
Sun-Zhao-Hui; Zheng-Wen-Ling; Peng-Yi-Fei; Zhang-Bao; Lu-Liang; Ma-Xiao-Dong; Ma-Wen-Li 2005: HCV genotype 1b microarray preparation using cDNA fragments library. Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao 21(3): 415-420
Coppola, N.; Vatiero, L.M.; Sagnelli, E. 2005: HCV genotype 2 as a risk factor for reactivation of chronic HCV infection. Gut 54(8): 1207
Tarantino, G.; Riccio, A.; Spanò, A.; Loi, G.; Padula, S.; Ladogana, P.; Postiglione, L.; Scarpa, R. 2006: HCV infection and chronic arthritis: Does viral replication matter?. Hepatology Research: the Official Journal of the Japan Society of Hepatology 35(4): 238-241
Chen, Y-Chun.; Kuo, M-Chuan.; Chen, H-Chun.; Lai, Y-Hsiung.; Hwang, S-Jyh. 2005: HCV infection complicated with nephrotic syndrome, immune complex crescentic glomerulonephritis and acute renal failure: a case report. Kaohsiung Journal of Medical Sciences 21(10): 470-474
Pugliese, A.; Gennero, L.; Cutufia, M.; Enrietto, M.; Morra, E.; Pescarmona, P.; Ponzetto, A. 2004: HCV infective virions can be carried by human platelets. Cell Biochemistry and Function 22(6): 353-358
Grassi, A.; Ballardini, G.; Susca, M.; Bianchini, F.; Bonoli, S.; Bianchi, F.B.; Lenzi, M. 2005: HCV liver infection and liver steatosis: evidence for indirect mechanisms in genotype 3?. Alimentary Pharmacology and Therapeutics 22(Suppl 2): 79-82
Ghaziani, T.; Shan, Y.; Lambrecht, R.W.; Donohue, S.E.; Pietschmann, T.; Bartenschlager, R.; Bonkovsky, H.L. 2006: HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells. Journal of Hepatology 45(1): 5-12
Operskalski, E.A.; Mosley, J.W.; Tobler, L.H.; Fiebig, E.W.; Nowicki, M.J.; Mimms, L.T.; Gallarda, J.; Phelps, B.H.; Busch, M.P. 2003: HCV viral load in anti-HCV-reactive donors and infectivity for their recipients. Transfusion 43(10): 1433-1441
Forns, X.; Costa, J. 2006: HCV virological assessment. Journal of Hepatology 44(1 Suppl): S35-S39
Sansonno, D.; Tucci, F.A.; De Re, V.; Lauletta, G.; Montrone, M.; Libra, M.; Dammacco, F. 2005: HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation. Hepatology 42(5): 1019-1027
El Hader, C.; Tremblay, S.; Solban, N.; Gingras, D.; Béliveau, R.; Orlov, S.N.; Hamet, P.; Tremblay, J. 2005: HCaRG increases renal cell migration by a TGF-alpha autocrine loop mechanism. American Journal of Physiology. Renal Physiology 289(6): F1273-F1280
Chi, Y.; Wen, J-Ming.; Zhang, D-Ping.; Yan, J-Hua.; Ni, M-Jiang.; Cen, K-Fa. 2005: HCl emission characteristics and BP neural networks prediction in MSW/coal co-fired fluidized beds. Journal of Environmental Sciences 17(4): 699-704
Cheng, L.; Cao, W.; Fiocchi, C.; Behar, J.; Biancani, P.; Harnett, K.M. 2006: HCl-induced inflammatory mediators in cat esophageal mucosa and inflammatory mediators in esophageal circular muscle in an in vitro model of esophagitis. American Journal of Physiology. Gastrointestinal and Liver Physiology 290(6): G1307-G1317
Du, Y.guo; Wei, Guohua; Cheng, Shuihong; Hua, Y.xia; Linhardt, Robert, J. 2006: HClO4-SiO2 catalyzed glycosylation using sugar trichloroacetimidates as glycosyl donors. Tetrahedron Letters 47(3): 307-310
Misra, A.K.; Tiwari, P.; Madhusudan, S.K. 2005: HClO4-SiO2 catalyzed per-O-acetylation of carbohydrates. Carbohydrate Research 340(2): 325-329
Seong, I.S.; Ivanova, E.; Lee, J.-M.; Choo, Y.S.; Fossale, E.; Anderson, M.; Gusella, J.F.; Laramie, J.M.; Myers, R.H.; Lesort, M.; MacDonald, M.E. 2005: HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Human Molecular Genetics 14(19): 2871-2880
Karamboulas, C.; Swedani, A.; Ward, C.; Al-Madhoun, A.S.; Wilton, S.; Boisvenue, S.; Ridgeway, A.G.; Skerjanc, I.S. 2006: HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage. Journal of Cell Science 119(Part 20): 4305-4314
Vulcano, F.; Ciccarelli, C.; Mattia, G.; Marampon, F.; Giampiero, M.; Milazzo, L.; Pascuccio, M.; Zani, B.M.; Giampaolo, A.; Hassan, H.J. 2006: HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers. Experimental Cell Research 312(9): 1590-1597
Place, R.F.; Noonan, E.J.; Giardina, C. 2005: HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. Biochemical Pharmacology 70(3): 394-406
Pathil, A.; Armeanu, S.; Venturelli, S.; Mascagni, P.; Weiss, T.S.; Gregor, M.; Lauer, U.M.; Bitzer, M. 2006: HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL. Hepatology 43(3): 425-434
Qiu, Y.; Zhao, Y.; Becker, M.; John, S.; Parekh, B.S.; Huang, S.; Hendarwanto, A.; Martinez, E.D.; Chen, Y.; Lu, H.; Adkins, N.L.; Stavreva, D.A.; Wiench, M.; Georgel, P.T.; Schiltz, R.L.; Hager, G.L. 2006: HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Molecular Cell 22(5): 669-679
Zeng, L.; Xiao, Q.; Margariti, A.; Zhang, Z.; Zampetaki, A.; Patel, S.; Capogrossi, M.C.; Hu, Y.; Xu, Q. 2006: HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. Journal of Cell Biology 174(7): 1059-1069
Serrador, J.M.; Cabrero, J.Román.; Sancho, D.; Mittelbrunn, Mía.; Urzainqui, A.; Sánchez-Madrid, F. 2004: HDAC6 deacetylase activity links the tubulin cytoskeleton with immune synapse organization. Immunity 20(4): 417-428
Kovacs, J.J.; Murphy, P.J.M.; Gaillard, S.ép.; Zhao, X.; Wu, J.-T.; Nicchitta, C.V.; Yoshida, M.; Toft, D.O.; Pratt, W.B.; Yao, T.-P. 2005: HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Molecular Cell 18(5): 601-607
Ammerpohl, O.; Thormeyer, D.; Khan, Z.; Appelskog, I.B.; Gojkovic, Z.; Almqvist, P.M.; Ekström, T.J. 2004: HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells. Biochemical and Biophysical Research Communications 324(1): 8-14
Place, R.F.; Noonan, E.J.; Giardina, C. 2005: HDACs and the senescent phenotype of WI-38 cells. Bmc Cell Biology 6: 37
Zhang, F.; Xiong, D.-H.; Wang, W.; Shen, H.; Xiao, P.; Yang, F.; Recker, R.R.; Deng, H.-W. 2006: HDC gene polymorphisms are associated with age at natural menopause in Caucasian women. Biochemical and Biophysical Research Communications 348(4): 1378-1382
Cohen, E.; Charba, D. 2005: HDD cannot be advocated for all patients. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 20(6): 1272; Author Reply 1272
Wang, C-Chieh.; Liao, Y-Pei.; Mischel, P.S.; Iwamoto, K.S.; Cacalano, N.A.; McBride, W.H. 2006: HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway. Cancer Research 66(13): 6756-6762
Shaul, P.W.; Mineo, C. 2004: HDL action on the vascular wall: is the answer NO?. Journal of Clinical Investigation 113(4): 509-513
Yokoyama, S. 2004: HDL and cholesterol homeostasis. Yakugaku Zasshi 124(Suppl 4): 53-56
Bigazzi, F.; Pino, B.Dal.; Forastiere, F.; Pistelli, R.; Rossi, G.; Simoni, M.; Baldacci, S.; Viegi, G.; Bionda, A.; Sampietro, T. 2004: HDL and clinical and biochemical correlates in Italian non-smoker women. Clinical Chemistry and Laboratory Medicine 42(12): 1408-1416
Brites, F.; Zago, V.; Verona, Ján.; Muzzio, Mía.Luz.; Wikinski, R.; Schreier, L. 2006: HDL capacity to inhibit LDL oxidation in well-trained triathletes. Life Sciences 78(26): 3074-3081
Assmann, G.; Gotto, A.M. 2004: HDL cholesterol and protective factors in atherosclerosis. Circulation 109(23 Suppl 1: Iii8
North, K.E.; Martin, L.J.; Dyer, T.; Comuzzie, A.G.; Williams, J.T. 2004: HDL cholesterol in females in the Framingham Heart Study is linked to a region of chromosome 2q. Bmc Genetics 4(Suppl): S98
Meurs, I.; Hoekstra, M.; van Wanrooij, E.J.A.; Hildebrand, R.B.; Kuiper, J.; Kuipers, F.; Hardeman, M.R.; Van Berkel, T.J.C.; Van Eck, M. 2005: HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes. Experimental Hematology 33(11): 1309-1319
Tan, K.C.B.; Chow, W.-S.; Lam, J.C.M.; Lam, B.; Wong, W.-K.; Tam, S.; Ip, M.S.M. 2006: HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184(2): 377-382
Matsuura, F.; Wang, N.; Chen, W.; Jiang, X-Cheng.; Tall, A.R. 2006: HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. Journal of Clinical Investigation 116(5): 1435-1442
Nofer, J-Roch.; van der Giet, M.; Tölle, M.; Wolinska, I.; von Wnuck Lipinski, K.; Baba, H.A.; Tietge, U.J.; Gödecke, A.; Ishii, I.; Kleuser, B.; Schäfers, M.; Fobker, M.; Zidek, W.; Assmann, G.; Chun, J.; Levkau, B. 2004: HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. Journal of Clinical Investigation 113(4): 569-581
Brites, F.; Verona, J.; Fernández, K.; Henriksen, F.; Fruchart, J.; Cesar, M.; Castro, G.; Wikinski, R. 2004: HDL metabolic activities in a boy with lipoprotein lipase deficiency and his family. European Journal of Clinical Investigation 34(7): 467-474
Rosenson, R.S. 2005: HDL-C and the diabetic patient: target for therapeutic intervention?. Diabetes Research and Clinical Practice 68(Suppl 2): S36-S42
Norata, G.D.; Callegari, E.; Inoue, H.; Catapano, A.L. 2004: HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling. Arteriosclerosis Thrombosis and Vascular Biology 24(5): 871-877
Sampietro, T.; Bigazzi, F.; Dal Pino, B.; Puntoni, M.; Bionda, A. 2006: HDL: the 'new' target of cardiovascular medicine. International Journal of Cardiology 108(2): 143-154
Barter, P. 2004: HDL: a recipe for longevity. ATHEROSCLEROSIS. Suppls 5(2): 25-31
Lee, J.-Y.; Timmins, J.M.; Mulya, A.; Smith, T.L.; Zhu, Y.; Rubin, E.M.; Chisholm, J.W.; Colvin, P.L.; Parks, J.S. 2005: HDLs in apoA-i transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney. Journal of Lipid Research 46(10): 2233-2245
Puff, N.; Lamazière, A.; Seigneuret, M.; Trugnan, G.; Angelova, M.I. 2005: HDLs induce raft domain vanishing in heterogeneous giant vesicles. Chemistry and Physics of Lipids 133(2): 195-202
Bjørling-Poulsen, M.; Meek, D.; Issinger, O.-G. 2005: HDM2 negatively affects the Chk2-mediated phosphorylation of p53. Febs Letters 579(12): 2604-2608
Martínez, J-C.; Palomino, J-C.; Cabello, A.; Sepúlveda, J.M.; de la Cámara, A.G.; Ricoy, J-R. 2005: HDM2 overexpression and focal loss of p14/ARF expression may deregulate the p53 tumour suppressor pathway in meningeal haemangiopericytomas. Study by double immunofluorescence and laser scanning confocal microscopy. Histopathology 46(2): 184-194
Yau, T.-On; Chan, C.-Yiu; Chan, K.-Lung; Lee, M.-Fong; Wong, C.-Ming; Fan, S.-Tat; Ng, I.-Oi-Lin 2005: HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing. Oncogene 24(9): 1607-1614
Aksoylar, S.; Aydinok, Yşim.; Serdaroğlu, E.; Coker, M.; Ozdemir, F.; Ozkinay, F. 2004: HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome presenting with hypocalcemia-induced generalized psoriasis. Journal of Pediatric Endocrinology and Metabolism: Jpem 17(7): 1031-1034
Perrotta, A.T.; Been, M.D. 2006: HDV ribozyme activity in monovalent cations. Biochemistry 45(38): 11357-11365
Légaré, C.; Thabet, M.; Gatti, J.-L.; Sullivan, R. 2006: HE1/NPC2 status in human reproductive tract and ejaculated spermatozoa: consequence of vasectomy. Molecular Human Reproduction 12(7): 461-468
Anonymous 2004: HEALTHYPIGUT Workshop 1 - Digestive Physiology, Microbiology and Immunology: Basis for Gut Function and Dysfunction in Pigs, Rostock-Warnemuende, Germany, September 12, 2003. Animal Research 53(4): 335-339
Martin-Serrano, J.; Eastman, S.W.; Chung, W.; Bieniasz, P.D. 2005: HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. Journal of cell biology 168(1): 89-101
Pugacheva, E.N.; Golemis, E.A. 2006: HEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks. Cell Cycle 5(4): 384-391
Zintzaras, E.; Ioannidis, J.P.A. 2005: HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21(18): 3672-3673
Ryu, J.H.; Kim, S.-S.; Cho, S.-W.; Choi, C.Y.; Kim, B.-S. 2004: HEK 293 cell suspension culture using fibronectin-adsorbed polymer nanospheres in serum-free medium. Journal of Biomedical Materials Research. Part a 71(1): 128-133
Thomas, P.; Smart, T.G. 2005: HEK293 cell line: a vehicle for the expression of recombinant proteins. Journal of Pharmacological and Toxicological Methods 51(3): 187-200
Mindikoglu, A.L.; Li, S.D.; Yong, S.L.; Borge, M.A.; Brems, J.; Van Thiel, D.H. 2006: HELLP syndrome complicated bile duct injury and subsequent left hepatic lobe atrophy. Digestive Diseases and Sciences 51(7): 1206-1212
Yang, Z.; Ebright, Y.W.; Yu, B.; Chen, X. 2006: HEN1 recognizes 21-24 nt small RNA duplexes and deposits a methyl group onto the 2' OH of the 3' terminal nucleotide. Nucleic Acids Research 34(2): 667-675
Wein, L.M.; Liu, Y.; Leighton, T.J. 2005: HEPA/vaccine plan for indoor anthrax remediation. Emerging Infectious Diseases 11(1): 69-76
Moh, M.Chung.; Lee, L.Hoon.; Yang, X.; Shen, S. 2003: HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells. Journal of Hepatology 39(4): 580-586
Zúbor, P.; Vojvodová, A.; Danko, J.; Kajo, K.; Szunyogh, N.; Lasabová, Z.; Biringer, K.; Visnovský, J.; Dókus, K.; Galajda, P.; Plank, L. 2006: HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia. Neoplasma 53(1): 49-55
Oakley, G.J.; Tubbs, R.R.; Crowe, J.; Sebek, B.; Budd, G.Thomas.; Patrick, R.J.; Procop, G.W. 2006: HER-2 amplification in tubular carcinoma of the breast. American Journal of Clinical Pathology 126(1): 55-58
Liu, F.; Jiang, Z-Fei.; Song, S-Tai.; Sun, J-Zhong.; Zhang, S-Hua.; Feng, S-Qiang. 2006: HER-2 and ER expression in prediction of chemo-sensitivity of taxane for advanced breast cancer. Zhonghua Zhong Liu Za Zhi 28(6): 449-451
Simon, R.; Atefy, R.; Wagner, U.; Forster, T.; Fijan, A.é; Bruderer, J.; Wilber, K.; Mihatsch, M.J.; Gasser, T.; Sauter, G. 2003: HER-2 and TOP2A coamplification in urinary bladder cancer. International Journal of Cancer 107(5): 764-772
Persons, D.L.; Tubbs, R.R.; Cooley, L.D.; Dewald, G.W.; Dowling, P.K.; Du, E.; Mascarello, J.T.; Rao, K.W.; Wilson, K.S.; Wolff, D.J.; Habegger-Vance, G. 2006: HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists. Archives of Pathology and Laboratory Medicine 130(3): 325-331
Meng, S.; Tripathy, D.; Shete, S.; Ashfaq, R.; Haley, B.; Perkins, S.; Beitsch, P.; Khan, A.; Euhus, D.; Osborne, C.; Frenkel, E.; Hoover, S.; Leitch, M.; Clifford, E.; Vitetta, E.; Morrison, L.; Herlyn, D.; Terstappen, L.W.M.M.; Fleming, T.; Fehm, T.; Tucker, T.; Lane, N.; Wang, J.; Uhr, J. 2004: HER-2 gene amplification can be acquired as breast cancer progresses. Proceedings of the National Academy of Sciences of the United States of America 101(25): 9393-9398
Bianco, M.K.; Vasef, M.A. 2006: HER-2 gene amplification in Paget disease of the nipple and extramammary site: a chromogenic in situ hybridization study. Diagnostic Molecular Pathology: the American Journal of Surgical Pathology Part B 15(3): 131-135
Half, E.; Broaddus, R.; Danenberg, K.D.; Danenberg, P.V.; Ayers, G.D.; Sinicrope, F.A. 2004: HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors. International Journal of Cancer 108(4): 540-548
Ciampa, A.; Xu, B.; Ayata, G.; Baiyee, D.; Wallace, J.; Wertheimer, M.; Edmiston, K.; Khan, A. 2006: HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system. Applied Immunohistochemistry and Molecular Morphology: Aimm 14(2): 132-137
Lal, P.; Salazar, P.A.; Hudis, C.A.; Ladanyi, M.; Chen, B. 2004: HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: a single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring. American Journal of Clinical Pathology 121(5): 631-636
Yaziji, H.; Goldstein, L.C.; Barry, T.S.; Werling, R.; Hwang, H.; Ellis, G.K.; Gralow, J.R.; Livingston, R.B.; Gown, A.M. 2004: HER-2 testing in breast cancer using parallel tissue-based methods. JAMA 291(16): 1972-1977
Brattström, D.; Wester, K.; Bergqvist, M.; Hesselius, P.; Malmström, P-Uno.; Nordgren, H.; Wagenius, G.; Brodin, O. 2004: HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer. Acta Oncologica 43(1): 80-86
Liu, G.; Ying, H.; Zeng, G.; Wheeler, C.J.; Black, K.L.; Yu, J.S. 2004: HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. Cancer Research 64(14): 4980-4986
Andersson, J.; Linderholm, B.; Bergh, J.; Elmberger, G. 2004: HER-2/neu (c-erbB-2) evaluation in primary breast carcinoma by fluorescent in situ hybridization and immunohistochemistry with special focus on intratumor heterogeneity and comparison of invasive and in situ components. Applied Immunohistochemistry and Molecular Morphology: Aimm 12(1): 14-20
Bozzetti, C.; Personeni, N.; Nizzoli, R.; Guazzi, A.; Flora, M.; Bassano, C.; Negri, F.; Martella, E.; Naldi, N.; Franciosi, V.; Cascinu, S. 2003: HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma. Cancer 99(5): 310-315
Park, D.Il.; Yun, J.Won.; Park, J.Ho.; Oh, S.Joong.; Kim, H.Joo.; Cho, Y.Kyun.; Sohn, C.Il.; Jeon, W.Kyu.; Kim, B.Ik.; Yoo, C.Hak.; Son, B.Ho.; Cho, E.Yoon.; Chae, S.Wan.; Kim, E-Jin.; Sohn, J.Hee.; Ryu, S.Ho.; Sepulveda, A.R. 2006: HER-2/neu amplification is an independent prognostic factor in gastric cancer. Digestive Diseases and Sciences 51(8): 1371-1379
Raspollini, M.Rosaria.; Amunni, G.; Villanucci, A.; Castiglione, F.; Rossi Degl'Innocenti, D.; Baroni, G.; Paglierani, M.; Taddei, G.Luigi. 2006: HER-2/neu and bcl-2 in ovarian carcinoma: clinicopathologic, immunohistochemical, and molecular study in patients with shorter and longer survival. Applied Immunohistochemistry and Molecular Morphology: Aimm 14(2): 181-186
Tsai, J.Y.; Aviv, H.; Benevenia, J.; Chang, V.T.; Patterson, F.; Aisner, S.; Hameed, M. 2004: HER-2/neu and p53 in osteosarcoma: an immunohistochemical and fluorescence in situ hybridization analysis. Cancer Investigation 22(1): 16-24
Maru, D.; Middleton, L.P.; Wang, S.; Valero, V.; Sahin, A. 2005: HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger. Cancer 103(5): 900-905
Di Leo, A.; Chan, S.; Paesmans, M.; Friedrichs, K.; Pinter, T.; Cocquyt, V.; Murray, E.; Bodrogi, I.; Walpole, E.; Lesperance, B.; Korec, S.; Crown, J.; Simmonds, P.; Von Minckwitz, G.; Leroy, J.Y.; Durbecq, V.; Isola, J.; Aapro, M.; Piccart, M.J.; Larsimont, D. 2004: HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel. Breast Cancer Research and Treatment 86(3): 197-206
Kaumaya, Pravin, T.P. 2006: HER-2/neu cancer vaccines: Present status and future prospects. International Journal of Peptide Research and Therapeutics 12(1): 65-77
Beatty, B.G.; Bryant, R.; Wang, W.; Ashikaga, T.; Gibson, P.C.; Leiman, G.; Weaver, D.L. 2004: HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis. American Journal of Clinical Pathology 122(2): 246-255
Nizzoli, R.; Guazzi, A.; Naldi, N.; Fraciosi, V.; Bozzetti, C. 2005: HER-2/neu evaluation by fluorescence in situ hybridization on destained cytologic smears from primary and metastatic breast cancer. Acta Cytologica 49(1): 27-30
Muñoz-Gonzalez, D.; Zeichner-Gancz, I.; Candelaria, M.; Ramirez-Ugalde, M.T.; Perez-Sanchez, M.; Cervantes-Vazquez, G.; Cantu-de Leon, D.; Mora-Tizcareño, A.; Leonor-Ortíz, J. 2005: Her-2/neu expression as a predictive factor for response to anthracycline-based chemotherapy in a mexican population of locally advanced breast cancer patients. Medical Oncology 22(1): 23-28
Learn, P.A.; Yeh, I.-T.; McNutt, M.; Chisholm, G.B.; Pollock, B.H.; Rousseau, D.L.; Sharkey, F.E.; Cruz, A.B.; Kahlenberg, M.S. 2005: HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma. Cancer 103(11): 2252-2260
Brummer, O.; Stegner, H.-E.; Böhmer, G.; Kühnle, H.; Petry, K.-U. 2004: HER-2/neu expression in Paget disease of the vulva and the female breast. Gynecologic Oncology 95(2): 336-340
Konecny, G.E.; Thomssen, C.; Lück, H.J.; Untch, M.; Wang, H.-J.; Kuhn, W.; Eidtmann, H.; du Bois, A.; Olbricht, S.; Steinfeld, D.; Möbus, V.; von Minckwitz, G.; Dandekar, S.; Ramos, L.; Pauletti, G.; Pegram, M.D.; Jänicke, F.; Slamon, D.J. 2004: Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer. Journal of the National Cancer Institute 96(15): 1141-1151
Mayr, D.; Kanitz, V.; Amann, G.; Engel, J.; Burges, A.; Löhrs, U.; Diebold, J. 2006: HER-2/neu gene amplification in ovarian tumours: a comprehensive immunohistochemical and FISH analysis on tissue microarrays. Histopathology 48(2): 149-156
Lôrincz, Tás.; Tóth, József.; Badalian, G.; Tímár, József.; Szendrôi, Mós. 2006: HER-2/neu genotype of breast cancer may change in bone metastasis. Pathology Oncology Research: Por 12(3): 149-152
Rossi, E.; Villanacci, V.; Bassotti, G.; Casa, D.Della.; Missale, G.; Minelli, L.; Cestari, R. 2006: Her-2/neu in barrett esophagus: a comparative study between histology, immunohistochemistry, and fluorescence in situ hybridization. Diagnostic Molecular Pathology: the American Journal of Surgical Pathology Part B 15(3): 125-130
Rossi, E.; Ubiali, A.; Cadei, M.; Balzarini, P.; Valagussa, E.; Lucini, L.; Alpi, F.; Galletti, A.; Fontana, L.; Tedoldi, C.; Grigolato, P. 2006: HER-2/neu in breast cancer: a comparative study between histology, immunohistochemistry, and molecular technique (FISH). Applied Immunohistochemistry and Molecular Morphology: Aimm 14(2): 127-131
Chang, E.; Lee, A.; Lee, E.; Lee, H.; Shin, O.; Oh, S.; Kang, C. 2004: HER-2/neu oncogene amplification by chromogenic in situ hybridization in 130 breast cancers using tissue microarray and clinical follow-up studies. Journal of Korean Medical Science 19(3): 390-396
Raspollini, M.Rosaria.; Mecacci, F.; Paglierani, M.; Marchionni, M.; Taddei, G.Luigi. 2005: HER-2/neu oncogene in uterine carcinosarcoma on tamoxifen therapy. Pathology Research and Practice 201(2): 141-144
Mariani, A.; Sebo, T.J.; Katzmann, J.A.; Riehle, D.L.; Dowdy, S.C.; Keeney, G.L.; Lesnick, T.G.; Podratz, K.C. 2005: HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature. Anticancer Research 25(4): 2921-2927
Dragowska, W.H.; Warburton, C.; Yapp, D.T.T.; Minchinton, A.I.; Hu, Y.; Waterhouse, D.N.; Gelmon, K.; Skov, K.; Woo, J.; Masin, D.; Huxham, L.A.; Kyle, A.H.; Bally, M.B. 2004: HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization. Molecular Cancer Research: Mcr 2(11): 606-619
Tan, D.; Deeb, G.; Wang, J.; Slocum, H.K.; Winston, J.; Wiseman, S.; Beck, A.; Sait, S.; Anderson, T.; Nwogu, C.; Ramnath, N.; Loewen, G. 2003: HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization. Diagnostic Molecular Pathology: the American Journal of Surgical Pathology Part B 12(4): 201-211
Hsu, M.-C.; Chang, H.-C.; Hung, W.-C. 2006: HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. Journal of Biological Chemistry 281(8): 4718-4725
Lear-Kaul, K.C.; Yoon, H-Ryoung.; Kleinschmidt-DeMasters, B.K.; McGavran, L.; Singh, M. 2003: Her-2/neu status in breast cancer metastases to the central nervous system. Archives of Pathology and Laboratory Medicine 127(11): 1451-1457
Subbaramaiah, K.; Howe, L.R.; Port, E.R.; Brogi, E.; Fishman, J.; Liu, C.H.; Hla, T.; Hudis, C.; Dannenberg, A.J. 2006: HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism. Cancer Research 66(10): 5504-5511
Pectasides, D.; Gaglia, A.; Arapantoni-Dadioti, P.; Bobota, A.; Valavanis, C.; Kostopoulou, V.; Mylonakis, N.; Karabelis, A.; Pectasides, M.; Economopoulos, T. 2006: HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy. Anticancer Research 26(1b): 647-653
Herrmann, F.; Lehr, H.-A.; Drexler, I.; Sutter, G.; Hengstler, J.; Wollscheid, U.; Seliger, B. 2004: HER-2/neu-mediated regulation of components of the MHC class i antigen-processing pathway. Cancer Research 64(1): 215-220
Pupa, S.M.; Tagliabue, E.; Ménard, S.; Anichini, A. 2005: HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine. Journal of Cellular Physiology 205(1): 10-18
López-Guerrero, J.é A.; Llombart-Cussac, A.; Noguera, R.; Navarro, S.; Pellin, A.; Almenar, S.; Vazquez-Alvadalejo, C.; Llombart-Bosch, A. 2006: HER2 amplification in recurrent breast cancer following breast-conserving therapy correlates with distant metastasis and poor survival. International Journal of Cancer 118(7): 1743-1749
Ellis, C.M.; Dyson, M.J.; Stephenson, T.J.; Maltby, E.L. 2005: HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques. Journal of Clinical Pathology 58(7): 710-714
Tapia, C.; Schraml, P.; Simon, R.; Al-Kuraya, K.S.; Maurer, R.; Mirlacher, M.; Novotny, H.; Spichtin, H.; Mihatsch, M.J.; Sauter, G. 2004: HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies. International Journal of Oncology 25(6): 1551-1557
Pritchard, K.I.; Shepherd, L.E.; O'Malley, F.P.; Andrulis, I.L.; Tu, D.; Bramwell, V.H.; Levine, M.N. 2006: HER2 and responsiveness of breast cancer to adjuvant chemotherapy. New England Journal of Medicine 354(20): 2103-2111
Millikan, R.C.; Hummer, A.J.; Wolff, M.S.; Hishida, A.; Begg, C.B. 2005: HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case-control analyses. Breast Cancer Research and Treatment 89(3): 309-312
Risio, M.; Casorzo, L.; Redana, S.; Montemurro, F. 2005: HER2 gene-amplified breast cancers with monosomy of chromosome 17 are poorly responsive to trastuzumab-based treatment. Oncology Reports 13(2): 305-309
Vogl, G.; Bartel, H.; Dietze, O.; Hauser-Kronberger, C. 2006: HER2 is unlikely to be involved in directly regulating angiogenesis in human breast cancer. Applied Immunohistochemistry and Molecular Morphology: Aimm 14(2): 138-145
Wang, S.E.; Narasanna, A.; Perez-Torres, M.; Xiang, B.; Wu, F.Y.; Yang, S.; Carpenter, G.; Gazdar, A.F.; Muthuswamy, S.K.; Arteaga, C.L. 2006: HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors. Cancer Cell 10(1): 25-38
Hirata, A.; Hosoi, F.; Miyagawa, M.; Ueda, S.-i.; Naito, S.; Fujii, T.; Kuwano, M.; Ono, M. 2005: HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells. Cancer Research 65(10): 4253-4260
Loring, P.; Cummins, R.; O'Grady, A.; Kay, E.W. 2005: HER2 positivity in breast carcinoma: a comparison of chromogenic in situ hybridization with fluorescence in situ hybridization in tissue microarrays, with targeted evaluation of intratumoral heterogeneity by in situ hybridization. Applied Immunohistochemistry and Molecular Morphology: Aimm 13(2): 194-200
Langner, C.; Gross, C.; Rehak, P.; Ratschek, M.; Rüschoff, J.; Zigeuner, R. 2005: HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: systematic analysis applying tissue microarray technique. Urology 65(1): 176-180
Dubská, L.; Andera, L.; Sheard, M.A. 2005: HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: an unexpected effect on TRAIL-induced apoptosis. Febs Letters 579(19): 4149-4158
Galmozzi, E.; Casalini, P.; Iorio, M.Valeria.; Casati, B.; Olgiati, C.; Ménard, S. 2004: HER2 signaling enhances 5'UTR-mediated translation of c-Myc mRNA. Journal of Cellular Physiology 200(1): 82-88
Shukla, R.; Thomas, T.P.; Peters, J.L.; Desai, A.M.; Kukowska-Latallo, J.; Patri, A.K.; Kotlyar, A.; Baker, J.R. 2006: HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. Bioconjugate Chemistry 17(5): 1109-1115
Park, K.; Han, S.; Kim, H.J.; Kim, J.; Shin, E. 2006: HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry. Histopathology 48(6): 702-707
Guillemard, V.; Nedev, H.N.; Berezov, A.; Murali, R.; Saragovi, H.U. 2005: HER2-mediated internalization of a targeted prodrug cytotoxic conjugate is dependent on the valency of the targeting ligand. Dna and Cell Biology 24(6): 350-358
Yamaguchi, Y.; Hironaka, K.; Okawaki, M.; Okita, R.; Matsuura, K.; Ohshita, A.; Toge, T. 2005: HER2-specific cytotoxic activity of lymphokine-activated killer cells in the presence of trastuzumab. Anticancer Research 25(2a): 827-832
Freeman, M.R. 2004: HER2/HER3 heterodimers in prostate cancer: Whither HER1/EGFR?. Cancer Cell 6(5): 427-428
Wang, S.Emily.; Shin, I.; Wu, F.Y.; Friedman, D.B.; Arteaga, C.L. 2006: HER2/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta. Cancer Research 66(19): 9591-9600
Dowdy, S.C.; Mariani, A.; Janknecht, R. 2003: HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81. Journal of Biological Chemistry 278(45): 44377-44384
Eissa, S.; Ali, H.S.; Al Tonsi, A.H.; Zaglol, A.; El Ahmady, O. 2005: HER2/neu expression in bladder cancer: relationship to cell cycle kinetics. Clinical Biochemistry 38(2): 142-148
Mellinghoff, I.K.; Vivanco, I.; Kwon, A.; Tran, C.; Wongvipat, J.; Sawyers, C.L. 2004: HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability. Cancer Cell 6(5): 517-527
Verri, E.; Guglielmini, P.; Puntoni, M.; Perdelli, L.; Papadia, A.; Lorenzi, P.; Rubagotti, A.; Ragni, N.; Boccardo, F. 2005: HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study. Oncology 68(2-3): 154-161
Zhu-Xiaofeng; Zhou-Junmin; Xie-Bingfen; Et-Al 2004: HER2/neu tyrosine kinase inhibitor SUCI02 induces cell cycle arrest in HER2/neu-overexpressing breast cancer cells and its mechanism. Zhongguo Zhongliu Linchuang 31(22): 1261-1264
Siwak, D.R.; Mendoza-Gamboa, E.; Tari, A.M. 2003: HER2/neu uses Akt to suppress retinoic acid response element binding activity in MDA-MB-453 breast cancer cells. International Journal of Oncology 23(6): 1739-1745
Arens, N.; Bleyl, U.; Hildenbrand, R. 2005: HER2/neu, p53, Ki67, and hormone receptors do not change during neoadjuvant chemotherapy in breast cancer. Virchows Archiv: An International Journal of Pathology 446(5): 489-496
Ishihara, Y.; Harada, M.; Azuma, K.; Tamura, M.; Shomura, H.; Fujii, T.; Itoh, K.; Shichijo, S. 2004: HER2/neu-derived peptides recognized by both cellular and humoral immune systems in HLA-A2+ cancer patients. International Journal of Oncology 24(4): 967-975
Howe, L.R.; Chang, S-Hee.; Tolle, K.C.; Dillon, R.; Young, L.J.T.; Cardiff, R.D.; Newman, R.A.; Yang, P.; Thaler, H.T.; Muller, W.J.; Hudis, C.; Brown, A.M.C.; Hla, T.; Subbaramaiah, K.; Dannenberg, A.J. 2005: HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Research 65(21): 10113-10119
Wong, J.J.Y.; Pung, Y.F.; Sze, N.S.-K.; Chin, K.-C. 2006: HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type i IFN-induced ISGylation of protein targets. Proceedings of the National Academy of Sciences of the United States of America 103(28): 10735-10740
Kroismayr, R.; Baranyi, U.; Stehlik, C.; Dorfleutner, A.; Binder, B.R.; Lipp, J. 2004: HERC5, a HECT E3 ubiquitin ligase tightly regulated in LPS activated endothelial cells. Journal of Cell Science 117(Pt 20): 4749-4756
Han, H.; Wang, J.; Zhang, Y.; Long, H.; Wang, H.; Xu, D.; Wang, Z. 2004: HERG K channel conductance promotes H2O2-induced apoptosis in HEK293 cells: cellular mechanisms. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 14(3): 121-134
Chen, S.-Z.; Jiang, M.; Zhen, Y.-s. 2005: HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin. Cancer ChemoTherapy and Pharmacology 56(2): 212-220
Berecki, Géza.; Zegers, J.G.; Verkerk, A.O.; Bhuiyan, Z.A.; de Jonge, B.; Veldkamp, M.W.; Wilders, R.; van Ginneken, A.C.G. 2004: HERG channel (dys)function revealed by dynamic action potential clamp technique. Biophysical Journal 88(1): 566-578
Paulussen, A.ée.D.C.; Raes, A.; Jongbloed, R.J.; Gilissen, R.A.H.J.; Wilde, A.A.M.; Snyders, D.J.; Smeets, H.J.M.; Aerssens, J. 2005: HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency. Cardiovascular Research 67(3): 467-475
Doi, H.; Iso, T.; Yamazaki, M.; Akiyama, H.; Kanai, H.; Sato, H.; Kawai-Kowase, K.; Tanaka, T.; Maeno, T.; Okamoto, E.-i.; Arai, M.; Kedes, L.; Kurabayashi, M. 2005: HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arteriosclerosis Thrombosis and Vascular Biology 25(11): 2328-2334
Paces, J.; Pavlícek, A.; Zika, R.; Kapitonov, V.V.; Jurka, J.; Paces, Václav. 2004: HERVd: the Human Endogenous RetroViruses Database: update. Nucleic Acids Research 32(Database Issue): D50
Lee, J-Seo.; Thomas, D.M.; Gutierrez, G.; Carty, S.A.; Yanagawa, S-ichi.; Hinds, P.W. 2006: HES1 cooperates with pRb to activate RUNX2-dependent transcription. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 21(6): 921-933
Yu, X.; Alder, J.K.; Chun, J.H.; Friedman, A.D.; Heimfeld, S.; Cheng, L.; Civin, C.I. 2006: HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding. Stem Cells 24(4): 876-888
Kim, T-Hyung.; Jeon, Y-Jin.; Kim, W-Yeon.; Kim, H-Soo. 2004: HESAS: HERVs Expression and Structure Analysis System. Bioinformatics 21(8): 1699-1700
Holderfield, M.T.; Henderson Anderson, A.M.; Kokubo, H.; Chin, M.T.; Johnson, R.L.; Hughes, C.C.W. 2006: HESR1/CHF2 suppresses VEGFR2 transcription independent of binding to E-boxes. Biochemical and Biophysical Research Communications 346(3): 637-648
Mantovani, G.; Asteria, C.; Pellegrini, C.; Bosari, S.; Alberti, L.; Bondioni, S.; Peverelli, E.; Spada, A.; Beck-Peccoz, P. 2006: HESX1 expression in human normal pituitaries and pituitary adenomas. Molecular and Cellular Endocrinology 247(1-2): 135-139
Lyra, A.C.; Pinho, J.R.R.; Silva, L.K.; Sousa, L.; Saraceni, C.P.; Braga, E.L.; Pereira, J.E.; Zarife, M.A.S.; Reis, M.G.; Lyra, L.G.C.; Silva, L.C.da.; Carrilho, F.J. 2005: HEV, TTV and GBV-C/HGV markers in patients with acute viral hepatitis. Brazilian Journal of Medical and Biological Research 38(5): 767-775
Poznański, J.ła.; Wszelaka-Rylik, M.łg.; Zielenkiewicz, W. 2005: HEW lysozyme salting by high-concentration NaCl solutions followed by titration calorimetry. Biophysical Chemistry 113(2): 137-144
Shimizu, N.; Ouchida, R.; Yoshikawa, N.; Hisada, T.; Watanabe, H.; Okamoto, K.; Kusuhara, M.; Handa, H.; Morimoto, C.; Tanaka, H. 2005: HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b. Proceedings of the National Academy of Sciences of the United States of America 102(24): 8555-8560
Mori, I.; Liu, B.; Goshima, F.; Ito, H.; Koide, N.; Yoshida, T.; Yokochi, T.; Kimura, Y.; Nishiyama, Y. 2005: HF10, an attenuated herpes simplex virus (HSV) type 1 clone, lacks neuroinvasiveness and protects mice against lethal challenge with HSV types 1 and 2. Microbes and Infection 7(15): 1492-1500
Hoja, U.; Marthol, S.; Hofmann, J.ör.; Stegner, S.; Schulz, R.; Meier, S.; Greiner, E.; Schweizer, E. 2004: HFA1 encoding an organelle-specific acetyl-CoA carboxylase controls mitochondrial fatty acid synthesis in Saccharomyces cerevisiae. Journal of Biological Chemistry 279(21): 21779-21786
Giannetti, A.M.; Björkman, P.J. 2004: HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface. Journal of Biological Chemistry 279(24): 25866-25875
de Almeida, Sérgio.F.; Carvalho, I.F.; Cardoso, C.S.; Cordeiro, Jão.V.; Azevedo, J.E.; Neefjes, J.; de Sousa, M. 2005: HFE cross-talks with the MHC class I antigen presentation pathway. Blood 106(3): 971-977
Carroll, G.J. 2006: HFE gene mutations are associated with osteoarthritis in the index or middle finger metacarpophalangeal joints. Journal of Rheumatology 33(4): 741-743
Martins, R.; Picanço, I.; Nunes, B.; Romão, Lísa.; Faustino, P. 2005: HFE gene mutations are extremely rare in Western sub-Saharan Africa. Annals of Hematology 84(10): 686-688
Sikorska, K.; Bielawski, K.Piotr.; Stalke, P.; Lakomy, E.Anna.; Michalska, Z.; Witczak-Malinowska, K.; Romanowski, T. 2005: HFE gene mutations in Polish patients with disturbances of iron metabolism: an initial assessment. International Journal of Molecular Medicine 16(6): 1151-1156
Gleeson, D.; Evans, S.; Bradley, M.; Jones, J.; Peck, R.J.; Dube, A.; Rigby, E.; Dalton, A. 2006: HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls. American Journal of Gastroenterology 101(2): 304-310
Simsek, H.; Balaban, Y.H.; Sümer, H.; Yilmaz, E.; Tatar, G. 2006: HFE mutations analysis of Turkish patients with nonalcoholic steatohepatitis. Digestive Diseases and Sciences 51(10): 1723-1724
Yen, A.A.; Simpson, E.P.; Henkel, J.S.; Beers, D.R.; Appel, S.H. 2004: HFE mutations are not strongly associated with sporadic ALS. Neurology 62(9): 1611-1612
Xue, R.; Wang, S.; Wang, C.; Zhu, T.; Li, F.; Sun, H. 2006: HFIP-induced structures and assemblies of the peptides from the transmembrane domain 4 of membrane protein Nramp1. Biopolymers 84(3): 329-339
Gerritsen, M.E. 2005: HGF and VEGF: a dynamic duo. Circulation Research 96(3): 272-273
Khoury, H.; Naujokas, M.A.; Zuo, D.; Sangwan, V.; Frigault, M.M.; Petkiewicz, S.; Dankort, D.L.; Muller, W.J.; Park, M. 2005: HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion. Molecular Biology of the Cell 16(2): 550-561
Madhavan, R.; Peng, H.B. 2006: HGF induction of postsynaptic specializations at the neuromuscular junction. Journal of Neurobiology 66(2): 134-147
Dabelsteen, S.; Christensen, S.; Gron, B.; Bardow, A.; Dabelsteen, E. 2005: HGF is released from buccal fibroblasts after smokeless tobacco stimulation. Oral Oncology 41(5): 509-514
Thompson, J.; Dolcet, X.; Hilton, M.; Tolcos, M.; Davies, A.M. 2004: HGF promotes survival and growth of maturing sympathetic neurons by PI-3 kinase- and MAP kinase-dependent mechanisms. Molecular and Cellular Neurosciences 27(4): 441-452
Kakazu, A.; Chandrasekher, G.; Bazan, H.E.P. 2004: HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway. IOVS Investigative Ophthalmology and Visual Science 45(10): 3485-3492
Mizuno, S.; Matsumoto, K.; Li, M-Yue.; Nakamura, T. 2005: HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 19(6): 580-582
Gutierrez, H.; Dolcet, X.; Tolcos, M.; Davies, A. 2004: HGF regulates the development of cortical pyramidal dendrites. Development 131(15): 3717-3726
Cohen, M.; Marchand-Adam, S.; Lecon-Malas, V.ér.; Marchal-Somme, J.ël.; Boutten, A.; Durand, G.èv.; Crestani, B.; Dehoux, M. 2006: HGF synthesis in human lung fibroblasts is regulated by oncostatin M. American Journal of Physiology. Lung Cellular and Molecular Physiology 290(6): L1097-L1103
Kanda, S.; Kanetake, H.; Miyata, Y. 2006: HGF-induced capillary morphogenesis of endothelial cells is regulated by Src. Biochemical and Biophysical Research Communications 344(2): 617-622
Tsarfaty, G.; Stein, G.Y.; Moshitch-Moshkovitz, S.; Kaufman, D.W.; Cao, B.; Resau, J.H.; Vande Woude, G.F.; Tsarfaty, I. 2006: HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met. Neoplasia 8(5): 344-352
Sentjens, R.; Basaras, M.; Simmonds, P.; Vrielink, H.; Reesink, H. 2003: HGV/GB virus C transmission by blood components in patients undergoing open-heart surgery. Transfusion 43(11): 1558-1562
Fredman, D.; Munns, G.; Rios, D.; Sjöholm, F.; Siegfried, M.; Lenhard, B.; Lehväslaiho, H.; Brookes, A.J. 2004: HGVbase: a curated resource describing human DNA variation and phenotype relationships. Nucleic Acids Research 32(Database Issue): D516-D519
Fecarotta, S.; Parenti, G.; Vajro, P.; Zuppaldi, A.; Della Casa, R.; Carbone, M.T.; Correra, A.; Torre, G.; Riva, S.; Dionisi-Vici, C.; Santorelli, F.M.; Andria, G. 2006: HHH syndrome (hyperornithinaemia, hyperammonaemia, homocitrullinuria), with fulminant hepatitis-like presentation. Journal of Inherited Metabolic Disease 29(1): 186-189
Hsieh, H.-C.; Hsieh, Y.-H.; Huang, Y.-H.; Shen, F.-C.; Tsai, H.-N.; Tsai, J.-H.; Lai, Y.-T.; Wang, Y.-T.; Chuang, W.-J.; Huang, W. 2005: HHR23A, a human homolog of Saccharomyces cerevisiae Rad23, regulates xeroderma pigmentosum C protein and is required for nucleotide excision repair. Biochemical and Biophysical Research Communications 335(1): 181-187
Misrahi, J.J.; Foster, J.A.; Shaw, F.E.; Cetron, M.S. 2004: HHS/CDC legal response to SARS outbreak. Emerging Infectious Diseases 10(2): 353-355
Yamamoto, K.; Yoshikawa, T.; Okamoto, S.; Yamaki, K.; Shimokata, K.; Nishiyama, Y. 2005: HHV-6 and 7 DNA loads in lung tissues collected from patients with interstitial pneumonia. Journal of Medical Virology 75(1): 70-75
Härmä, M.; Höckerstedt, K.; Lyytikäinen, O.; Lautenschlager, I. 2006: HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation. Journal of Medical Virology 78(6): 800-805
Härmä, M.; Loginov, R.; Piiparinen, H.; Halme, L.; Höckerstedt, K.; Lautenschlager, I. 2005: HHV-6-DNAemia related to CMV-DNAemia after liver transplantation. Transplantation Proceedings 37(2): 1230-1232
Cacheux, W.; Carbonell, N.; Rosmorduc, O.; Wendum, D.; Paye, F.; Poupon, R.; Chazouillères, O.; Gozlan, J. 2005: HHV-6-related acute liver failure in two immunocompetent adults: favourable outcome after liver transplantation and/or ganciclovir therapy. Journal of Internal Medicine 258(6): 573-578
Bursics, A.; Morvay, K.; Abrahám, K.; Marschalkó, M.; Kardos, M.; Járay, B.; Nagy, K. 2005: HHV-8 positive, HIV negative disseminated Kaposi's sarcoma complicating steroid dependent ulcerative colitis: a successfully treated case. Gut 54(7): 1049-1050
Camcioglu, Y.; Picard, C.; Lacoste, V.; Dupuis, Séphanie.; Akçakaya, N.; Cokura, H.; Kaner, Gültekin.; Demirkesen, C.; Plancoulaine, S.; Emile, J-François.; Gessain, A.; Casanova, J-Laurent. 2004: HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency. Journal of Pediatrics 144(4): 519-523
Coupland, S.E.; Charlotte, F.; Mansour, G.; Maloum, K.; Hummel, M.; Stein, H. 2005: HHV-8-associated T-cell lymphoma in a lymph node with concurrent peritoneal effusion in an HIV-positive man. American Journal of Surgical Pathology 29(5): 647-652
Pak, F.; Pyakural, P.; Kokhaei, P.; Kaaya, E.; Pourfathollah, A.A.; Selivanova, G.; Biberfeld, P. 2005: HHV-8/KSHV during the development of Kaposi's sarcoma: evaluation by polymerase chain reaction and immunohistochemistry. Journal of Cutaneous Pathology 32(1): 21-27
Song, G.; Liao, X.; Zhou, L.; Wu, L.; Feng, Y.; Han, Z.C. 2004: HI44a, an anti-CD44 monoclonal antibody, induces differentiation and apoptosis of human acute myeloid leukemia cells. Leukemia Research 28(10): 1089-1096
Ghogomu, S.M.; van Venrooy, S.; Ritthaler, M.; Wedlich, D.; Gradl, D. 2006: HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription. Journal of Biological Chemistry 281(3): 1755-1764
Chopin, V.; Leprince, D. 2006: HIC1 : le noeud du probleme en 17p 13.3 ?. M S (Medecine Sciences) 22(1): 54-61
Parrella, P.; Scintu, M.; Prencipe, M.; Poeta, M.L.; Gallo, A.P.; Rabitti, C.; Rinaldi, M.; Tommasi, S.; Paradiso, A.; Schittulli, F.; Valori, V.M.; Toma, S.; Altomare, V.; Fazio, V.M. 2005: HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast. Cancer Letters 222(1): 75-81
Tang, K.; Breen, E.C.; Wagner, H.; Brutsaert, T.D.; Gassmann, M.; Wagner, P.D. 2004: HIF and VEGF relationships in response to hypoxia and sciatic nerve stimulation in rat gastrocnemius. Respiratory Physiology and Neurobiology 144(1): 71-80
Paul, S.A.M.; Simons, J.W.; Mabjeesh, N.J. 2004: HIF at the crossroads between ischemia and carcinogenesis. Journal of Cellular Physiology 200(1): 20-30
Metzen, E.; Ratcliffe, P.J. 2004: HIF hydroxylation and cellular oxygen sensing. Biological Chemistry 385(3-4): 223-230
Isaacs, J.S.; Jung, Y.J.; Mole, D.R.; Lee, S.; Torres-Cabala, C.; Chung, Y.-L.; Merino, M.; Trepel, J.; Zbar, B.; Toro, J.; Ratcliffe, P.J.; Linehan, W.M.; Neckers, L. 2005: HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8(2): 143-153
Willam, C.; Maxwell, P.H.; Nichols, L.; Lygate, C.; Tian, Y.M.; Bernhardt, W.; Wiesener, M.; Ratcliffe, P.J.; Eckardt, K.-U.; Pugh, C.W. 2006: HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation. Journal of Molecular and Cellular Cardiology 41(1): 68-77
Rathmell, W.K.; Acs, G.; Simon, M.C.; Vaughn, D.J. 2004: HIF transcription factor expression and induction of hypoxic response genes in a retroperitoneal angiosarcoma. Anticancer Research 24(1): 167-169
Ockaili, R.; Natarajan, R.; Salloum, F.; Fisher, B.J.; Jones, D.; Fowler, A.A.; Kukreja, R.C. 2005: HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. American Journal of Physiology. Heart and Circulatory Physiology 289(2): H542-H548
Gray, M., J.; Zhang, J.; Ellis, L., M.; Semenza, G., L.; Evans, D., B.; Watowich, S., S.; Gallick, G., E. 2005: HIF-1 alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complexthat regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 24(19): 3110-3120
Schmid, T.; Zhou, J.; Brüne, B. 2004: HIF-1 and p53: communication of transcription factors under hypoxia. Journal of Cellular and Molecular Medicine 8(4): 423-431
Treinin, M.; Shliar, J.; Jiang, H.; Powell-Coffman, J.A.; Bromberg, Z.; Horowitz, M. 2003: HIF-1 is required for heat acclimation in the nematode Caenorhabditis elegans. Physiological Genomics 14(1): 17-24
Papandreou, I.; Cairns, R.A.; Fontana, L.; Lim, A.L.; Denko, N.C. 2006: HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metabolism 3(3): 187-197
Shimoda, L.A.; Fallon, M.; Pisarcik, S.; Wang, J.; Semenza, G.L. 2006: HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. American Journal of Physiology. Lung Cellular and Molecular Physiology 291(5): L941-L949
Eltzschig, H.K.; Abdulla, P.; Hoffman, E.; Hamilton, K.E.; Daniels, D.; Schönfeld, C.; Löffler, M.; Reyes, G.; Duszenko, M.; Karhausen, J.; Robinson, A.; Westerman, K.A.; Coe, I.R.; Colgan, S.P. 2005: HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. Journal of Experimental Medicine 202(11): 1493-1505
Kim, J.-w.; Tchernyshyov, I.; Semenza, G.L.; Dang, C.V. 2006: HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metabolism 3(3): 177-185
Mazure, N.M.; Brahimi-Horn, M.C.; Berta, M.él.A.; Benizri, E.; Bilton, R.L.; Dayan, F.éd.ér.; Ginouvès, A.; Berra, E.; Pouysségur, J. 2004: HIF-1: master and commander of the hypoxic world. a pharmacological approach to its regulation by siRNAs. Biochemical Pharmacology 68(6): 971-980
Zagórska, A.; Dulak, Józef. 2004: HIF-1: the knowns and unknowns of hypoxia sensing. Acta Biochimica Polonica 51(3): 563-585
Kairaitis, L.-Karolis; Wang, Y.; Gassmann, M.; Tay, Y.-Ching; Harris, D.-Charles-Hamlyn 2005: HIF-1alpha expression follows microvascular loss in advanced murine adriamycin nephrosis. American Journal of Physiology Renal Physiology 288(1): F198-F206
Matrone, C.; Pignataro, G.; Molinaro, P.; Irace, C.; Scorziello, A.; Di Renzo, G.F.; Annunziato, L. 2004: HIF-1alpha reveals a binding activity to the promoter of iNOS gene after permanent middle cerebral artery occlusion. Journal of Neurochemistry 90(2): 368-378
Nilsson, Hén.; Jögi, A.; Beckman, S.; Harris, A.L.; Poellinger, L.; Påhlman, S. 2005: HIF-2alpha expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia. Experimental Cell Research 303(2): 447-456
Moeller, B.J.; Dewhirst, M.W. 2006: HIF-I and tumour radiosensitivity. British Journal of Cancer 95(1): 1-5
Ramírez-Bergeron, D.L.; Runge, A.; Adelman, D.M.; Gohil, M.; Simon, M.Celeste. 2006: HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature. Developmental Cell 11(1): 81-92
Louis, N.A.; Hamilton, K.E.; Kong, T.; Colgan, S.P. 2005: HIF-dependent induction of apical CD55 coordinates epithelial clearance of neutrophils. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 19(8): 950-959
Koeppe, J.R.; Campbell, T.B.; Rapaport, E.L.; Wilson, C.C. 2006: HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia. Journal of Acquired Immune Deficiency Syndromes 41(2): 140-148
Kelberg, E.P.; Kovaltsova, S.V.; Alekseev, S.Y.; Fedorova, I.V.; Gracheva, L.M.; Evstukhina, T.A.; Korolev, V.G. 2005: HIM1, a new yeast Saccharomyces cerevisiae gene playing a role in control of spontaneous and induced mutagenesis. Mutation Research 578(1-2): 64-78
Sorbera, L.A.; Bayes, M. 2004: HIM2. Treatment of type 1 and type 2 diabetes insulin analogue. Drugs of the Future 29(1): 32-37
Krop, I.; Parker, M.T.; Bloushtain-Qimron, N.; Porter, D.; Gelman, R.; Sasaki, H.; Maurer, M.; Terry, M.B.; Parsons, R.; Polyak, K. 2005: HIN-1, an inhibitor of cell growth, invasion, and AKT activation. Cancer Research 65(21): 9659-9669
Katikireddi, S.Vittal. 2004: HINARI: bridging the global information divide. BMJ 328(7449): 1190-1193
Han, J.; Shui, J.-W.; Zhang, X.; Zheng, B.; Han, S.; Tan, T.-H. 2005: HIP-55 is important for T-cell proliferation, cytokine production, and immune responses. Molecular and Cellular Biology 25(16): 6869-6878
Lieu, H-Tu.; Batteux, Fédéric.; Simon, M-Thérèse.; Cortes, A.; Nicco, C.; Zavala, F.; Pauloin, A.; Tralhao, Jé.Guilherme.; Soubrane, O.; Weill, B.; Bréchot, C.; Christa, L. 2005: HIP/PAP accelerates liver regeneration and protects against acetaminophen injury in mice. Hepatology 42(3): 618-626
Hervieu, Vérie.; Christa, L.; Gouysse, Géraldine.; Bouvier, R.; Chayvialle, J-Alain.; Bréchot, C.; Scoazec, J-Yves. 2006: HIP/PAP, a member of the reg family, is expressed in glucagon-producing enteropancreatic endocrine cells and tumors. Human Pathology 37(8): 1066-1075
Hyun, T.S.; Rao, D.S.; Saint-Dic, D.; Michael, L.E.; Kumar, P.D.; Bradley, S.V.; Mizukami, I.F.; Oravecz-Wilson, K.I.; Ross, T.S. 2004: HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains. Journal of Biological Chemistry 279(14): 14294-14306
Hyun, T.S.; Ross, T.S. 2004: HIP1: trafficking roles and regulation of tumorigenesis. Trends in Molecular Medicine 10(4): 194-199
Lo, B.; Dornbrand, L.; Dubler, N.N. 2005: HIPAA and patient care: the role for professional judgment. JAMA 293(14): 1766-1771
Zhou, Z.; Liu, B.J. 2005: HIPAA compliant auditing system for medical images. Computerized Medical Imaging and Graphics: the Official Journal of the Computerized Medical Imaging Society 29(2-3): 235-241
Di Stefano, V.; Mattiussi, M.; Sacchi, A.; D'Orazi, G. 2005: HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations. Febs Letters 579(25): 5473-5480
Hofmann, T.G.; Stollberg, N.; Schmitz, M.L.; Will, H. 2003: HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Research 63(23): 8271-8277
Warkentin, T.E. 2006: HIT: lessons learned. Pathophysiology of Haemostasis and Thrombosis 35(1-2): 50-57
Hong-Brown, L.Q.; Brown, C.Randell.; Lang, C.H. 2005: HIV antiretroviral agents inhibit protein synthesis and decrease ribosomal protein S6 and 4EBP1 phosphorylation in C2C12 myocytes. Aids Research and Human Retroviruses 21(10): 854-862
Shaunak, S.; Teo, I.; Choi, J.-w.; Gazzard, B. 2003: HIV DNA two long terminal repeat circles: observations and interpretations. Aids 17(15): 2273-2274
Lazzari, S.; de Felici, A.; Sobel, H.; Bertagnolio, S. 2004: HIV drug resistance surveillance: summary of an April 2003 WHO consultation. Aids 18(Suppl): S49-S53
Wille-Reece, U.; Flynn, B.J.; Loré, K.; Koup, R.A.; Kedl, R.M.; Mattapallil, J.J.; Weiss, W.R.; Roederer, M.; Seder, R.A. 2005: HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proceedings of the National Academy of Sciences of the United States of America 102(42): 15190-15194
McCoubrie, J.E.; Kendrick, T.S.; Minchin, R.F. 2004: HIV LTR-dependent expression of Bax selectively induces apoptosis in Tat-positive cells. Biochemical and Biophysical Research Communications 325(4): 1459-1464
Larsen, J.E.; Massol, R.H.; Nieland, T.J.F.; Kirchhausen, T. 2004: HIV Nef-mediated major histocompatibility complex class i down-modulation is independent of Arf6 activity. Molecular Biology of the Cell 15(1): 323-331
Roland, M.E.; Elbeik, T.A.; Kahn, J.O.; Bamberger, J.D.; Coates, T.J.; Krone, M.R.; Katz, M.H.; Busch, M.P.; Martin, J.N. 2004: HIV RNA testing in the context of nonoccupational postexposure prophylaxis. Journal of Infectious Diseases 190(3): 598-604
Surendran, R.; Herman, P.; Cheng, Z.; Daly, T.J.; Ching Lee, J. 2004: HIV Rev self-assembly is linked to a molten-globule to compact structural transition. Biophysical Chemistry 108(1-3): 101-119
Rubio Demirovic, A.; Canadi, J.; Weiglhofer, W.; Scheidegger, P.; Jaussi, R.; Kurt, B.-H. 2003: HIV TAT basic peptide is not a high-affinity ligand for VEGF receptor 2. Biological Chemistry 384(10-11): 1435-1441
Paladugu, R.; Fu, W.; Conklin, B.S.; Lin, P.H.; Lumsden, A.B.; Yao, Q.; Chen, C. 2003: Hiv Tat protein causes endothelial dysfunction in porcine coronary arteries. Journal of Vascular Surgery 38(3): 549-55; Discussion 555-6
Chui, C.; Cheung, P.K.; Brumme, C.J.; Mo, T.; Brumme, Z.L.; Montaner, J.S.G.; Badley, A.D.; Harrigan, P.Richard. 2006: HIV VprR77Q mutation does not influence clinical response of individuals initiating highly active antiretroviral therapy. Aids Research and Human Retroviruses 22(7): 615-618
Subramanyam, S.; Hanna, L.E.; Venkatesan, P.; Sankaran, K.; Narayanan, P.R.; Swaminathan, S. 2004: HIV alters plasma and M. tuberculosis-induced cytokine production in patients with tuberculosis. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 24(2): 101-106
Portsmouth, S.; Stebbing, J.; Keyi, X.; Jianping, Z.; Guohua, P. 2003: HIV and AIDS in the People's Republic of China: a collaborative review. International Journal of Std and Aids 14(11): 757-761
McClelland, G.Michael.; Teplin, L.A.; Abram, K.M.; Jacobs, N. 2002: HIV and AIDS risk behaviors among female jail detainees: implications for public health policy. American Journal of Public Health 92(5): 818-825
Collman, R.G.; Perno, C-Federico.; Crowe, S.M.; Stevenson, M.; Montaner, L.J. 2003: HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions. Journal of Leukocyte Biology 74(5): 631-634
Bulsara, K.R.; Raja, A.; Owen, J. 2005: HIV and cerebral aneurysms. Neurosurgical Review 28(2): 92-95
McNeilly, L.G. 2005: HIV and communication. Journal of Communication Disorders 38(4): 303-310
Challine, D.; Pellegrin, B.; Bouvier-Alias, M.; Rigot, P.; Laperche, L.; Pawlotsky, J.-M. 2004: HIV and hepatitis C virus RNA in seronegative organ and tissue donors. Lancet 364(9445): 1611-1612
Bánki, Zán.; Stoiber, H.; Dierich, M.P. 2005: HIV and human complement: inefficient virolysis and effective adherence. Immunology Letters 97(2): 209-214
Heit, B.; Jones, G.; Knight, D.; Antony, J.M.; Gill, M.John.; Brown, C.; Power, C.; Kubes, P. 2006: HIV and other lentiviral infections cause defects in neutrophil chemotaxis, recruitment, and cell structure: immunorestorative effects of granulocyte-macrophage colony-stimulating factor. Journal of Immunology 177(9): 6405-6414
Schichman, S.A.; McClure, R.; Schaefer, R.F.; Mehta, P. 2004: HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum. American Journal of Hematology 77(3): 291-295
Sonnenberg, P.; Glynn, J.R.; Fielding, K.; Murray, J.; Godfrey-Faussett, P.; Shearer, S. 2004: HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV. Aids 18(4): 657-662
Kassu, A.; Mekonnen, A.; Bekele, A.; Abseno, N.; Melese, E.; Moges, F.; Wondmikun, Y.; Ota, F. 2004: HIV and syphilis infection among elderly people in northwest Ethiopia. Japanese Journal of Infectious Diseases 57(6): 264-267
Le Coeur, S.; Khlat, M.; Halembokaka, G.; Augereau-Vacher, C.; Batala-M'Pondo, G.; Baty, G.; Ronsmans, C. 2005: HIV and the magnitude of pregnancy-related mortality in Pointe Noire, Congo. Aids 19(1): 69-75
Laperche, S.; Morel, P.; Deschaseaux, M.; Bouchardeau, Fçoise.; Alimardani, G.; Guillaume, N.; Rouger, P.; Lefrère, J-Jacques. 2003: HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation. Transfusion 43(10): 1428-1432
Mauskopf, J.; Kitahata, M.; Kauf, T.; Richter, A.; Tolson, J. 2005: HIV antiretroviral treatment: early versus later. Journal of Acquired Immune Deficiency Syndromes 39(5): 562-569
Lagathu, C.; Kim, M.; Maachi, M.; Vigouroux, C.; Cervera, P.; Capeau, J.; Caron, M.; Bastard, J.-P. 2005: HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo. Biochimie 87(1): 65-71
Garden, G.A.; Guo, W.; Jayadev, S.; Tun, C.; Balcaitis, S.; Choi, J.; Montine, T.J.; Möller, T.; Morrison, R.S. 2004: HIV associated neurodegeneration requires p53 in neurons and microglia. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 18(10): 1141-1143
Maher, D.; Wu, X.; Schacker, T.; Horbul, J.; Southern, P. 2005: HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proceedings of the National Academy of Sciences of the United States of America 102(32): 11504-11509
Karlsson, I.; Antonsson, L.; Shi, Y.; Karlsson, A.; Albert, J.; Leitner, T.; Olde, Börn.; Owman, C.; Fenyö, E.Maria. 2003: HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use. Aids 17(18): 2561-2569
Yasuda, J. 2005: HIV budding and Tsg101. Virus 55(2): 281-286
Schols, D. 2006: HIV co-receptor inhibitors as novel class of anti-HIV drugs. Antiviral Research 71(2-3): 216-226
Yonkers, N.L.; Rodriguez, B.; Post, A.B.; Asaad, R.; Jones, L.; Lederman, M.M.; Lehmann, P.V.; Anthony, D.D. 2006: HIV coinfection impairs CD28-mediated costimulation of hepatitis C virus-specific CD8 cells. Journal of Infectious Diseases 194(3): 391-400
Pineda, J.A.; Romero-Gómez, M.; Díaz-García, F.; Girón-González, Jé.A.; Montero, Jé.L.; Torre-Cisneros, Ján.; Andrade, Rúl.J.; González-Serrano, M.; Aguilar, Jé.; Aguilar-Guisado, M.; Navarro, Jé.M.; Salmerón, J.; Caballero-Granado, F.J.; García-García, Jé.A. 2005: HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 41(4): 779-789
McClure, C.Patrick.; Tighe, P.J.; Robins, R.Adrian.; Bansal, D.; Bowman, C.A.; Kingston, M.; Ball, J.K. 2005: HIV coreceptor and chemokine ligand gene expression in the male urethra and female cervix. Aids 19(12): 1257-1265
Rakgoasi, S.Daniel. 2005: HIV counselling and testing of pregnant women attending antenatal clinics in Botswana, 2001. Journal of Health Population and Nutrition 23(1): 58-65
McArthur, J.C. 2004: HIV dementia: an evolving disease. Journal of Neuroimmunology 157(1-2): 3-10
Iweala, O.I. 2004: HIV diagnostic tests: an overview. Contraception 70(2): 141-147
Walsh, E.J.; Souza, S.; Gerschenson, M.; Shikuma, C.; Chow, D. 2004: HIV disease progression and limited antiretroviral treatment options for a HIV-1 infected individual with myoclonic epilepsy associated with ragged red fibers. Mitochondrion 4(2-3): 169-173
Duncombe, C.; Kerr, S.J.; Ruxrungtham, K.; Dore, G.J.; Law, M.G.; Emery, S.; Lange, J.M.; Phanuphak, P.; Cooper, D.A. 2005: HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting. Aids 19(2): 169-178
Valle, L. del; Pina Oviedo, S. 2006: HIV disorders of the brain; pathology and pathogenesis. Frontiers in Bioscience 11(1): 718-732
Smith, D.M.; Wong, J.K.; Hightower, G.K.; Ignacio, C.C.; Koelsch, K.K.; Petropoulos, C.J.; Richman, D.D.; Little, S.J. 2005: HIV drug resistance acquired through superinfection. Aids 19(12): 1251-1256
Kozal, M.J.; Amico, K.Rivet.; Chiarella, J.; Cornman, D.; Fisher, W.; Fisher, J.; Friedland, G. 2005: HIV drug resistance and HIV transmission risk behaviors among active injection drug users. Journal of Acquired Immune Deficiency Syndromes 40(1): 106-109
Sánchez, Mía.S.; Grant, R.M.; Porco, T.C.; Getz, W.M. 2006: HIV drug-resistant strains as epidemiologic sentinels. Emerging Infectious Diseases 12(2): 191-197
Dixit, N.M.; Perelson, A.S. 2005: HIV dynamics with multiple infections of target cells. Proceedings of the National Academy of Sciences of the United States of America 102(23): 8198-8203
van Wanrooij, E.J.A.; Happé, H.; Hauer, A.D.; de Vos, P.; Imanishi, T.; Fujiwara, H.; van Berkel, T.J.C.; Kuiper, J. 2005: HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arteriosclerosis Thrombosis and Vascular Biology 25(12): 2642-2647
Krambovitis, E.; Porichis, F.; Spandidos, D.A. 2005: HIV entry inhibitors: a new generation of antiretroviral drugs. Acta Pharmacologica Sinica 26(10): 1165-1173
Briz, V.ón.; Poveda, E.; Soriano, V. 2006: HIV entry inhibitors: mechanisms of action and resistance pathways. Journal of Antimicrobial ChemoTherapy 57(4): 619-627
Matsika-Claquin, M.D.; Massanga, M.; Ménard, D.; Mazi-Nzapako, J.; Ténegbia, J.-P.; Mandeng, M.-J.ël.; Willybiro-Sacko, J.; Fontanet, A.; Talarmin, A. 2004: HIV epidemic in Central African Republic: high prevalence rates in both rural and urban areas. Journal of Medical Virology 72(3): 358-362
Rüütel, K.; Uusküla, A. 2006: HIV epidemic in Estonia in the third decade of the AIDS era. Scandinavian Journal of Infectious Diseases 38(3): 181-186
Rapatski, B.L.; Suppe, F.; Yorke, J.A. 2005: HIV epidemics driven by late disease stage transmission. Journal of Acquired Immune Deficiency Syndromes 38(3): 241-253
Veiga, A.Salomé.; Santos, N.C.; Loura, Lís.M.S.; Fedorov, A.; Castanho, M.A.R.B. 2004: HIV fusion inhibitor peptide T-1249 is able to insert or adsorb to lipidic bilayers. Putative correlation with improved efficiency. Journal of the American Chemical Society 126(45): 14758-14763
Jülg, B.; Goebel, F.D. 2005: HIV genetic diversity: any implications for drug resistance?. Infection 33(4): 299-301
Wang, H.-Gene-Heidi; Kadow, J.; Lin, P.-Fang 2005: HIV gp120 envelope as a therapeutic target. Drugs of the Future 30(4): 359-367
Solorio, M.R.; Currier, J.; Cunningham, W. 2004: HIV health care services for Mexican migrants. JAIDS Journal of Acquired Immune Deficiency Syndromes 37(Suppl 4): S240-S251
del Amo, J.; Bröring, G.; Fenton, K. 2003: HIV health experiences among migrant Africans in Europe: how are we doing?. Aids 17(15): 2261-2263
Taggart, B.R.; Harrington, P.; Hollingshead, M. 2004: HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model. Antiviral Research 63(1): 1-6
Gichangi, P.; Bwayo, J.; Estambale, B.; Rogo, K.; Njuguna, E.; Ojwang, S.; Temmerman, M. 2006: HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancer. Gynecologic Oncology 100(2): 405-411
Tachado, S.D.; Zhang, J.; Zhu, J.; Patel, N.; Koziel, H. 2005: HIV impairs TNF-alpha release in response to Toll-like receptor 4 stimulation in human macrophages in vitro. American Journal of Respiratory Cell and Molecular Biology 33(6): 610-621
Rogers, M.Chatterjee.; Gopalakrishnan, G.; Kumarasamy, N.; Flanigan, T.P.; Carpenter, C.C.J.; Mayer, K.H.; Solomon, S. 2005: HIV in couples in South India; implications for prevention. International Journal of Std and Aids 16(6): 442-445
Wodak, A.; Ali, R.; Farrell, M. 2004: HIV in injecting drug users in Asian countries. BMJ 329(7468): 697-698
Deren, S.; Kang, S-Yeon.; Colón, H.M.; Andia, J.F.; Robles, R.R. 2004: HIV incidence among high-risk Puerto Rican drug users: a comparison of East Harlem, New York, and Bayamón, Puerto Rico. Journal of Acquired Immune Deficiency Syndromes 36(5): 1067-1074
Des Jarlais, D.C.; Perlis, T.; Arasteh, K.; Torian, L.V.; Beatrice, S.; Milliken, J.; Mildvan, D.; Yancovitz, S.; Friedman, S.R. 2005: HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. American Journal of Public Health 95(8): 1439-1444
Ruan, Y.; Qin, G.; Liu, S.; Qian, H.; Zhang, L.; Zhou, F.; He, Y.; Chen, K.; Yin, L.; Chen, X.; Hao, Q.; Xing, H.; Song, Y.; Wang, Y.; Hong, K.; Chen, J.; Shao, Y. 2005: HIV incidence and factors contributed to retention in a 12-month follow-up study of injection drug users in Sichuan Province, China. Journal of Acquired Immune Deficiency Syndromes 39(4): 459-463
Murphy, G.; Charlett, A.; Jordan, L.F.; Osner, N.; Gill, O.Noel.; Parry, J.V. 2004: HIV incidence appears constant in men who have sex with men despite widespread use of effective antiretroviral therapy. Aids 18(2): 265-272
Harman, A.N.; Wilkinson, J.; Bye, C.R.; Bosnjak, L.; Stern, J.Lewis.; Nicholle, M.; Lai, J.; Cunningham, A.L. 2006: HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. Journal of Immunology 177(10): 7103-7113
Srirak, N.; Kawichai, S.; Vongchak, T.; Razak, M.H.; Jittiwuttikarn, J.; Tovanabutra, S.; Rungruengthanakit, K.; Keawvichit, R.; Beyrer, C.; Wiboonatakul, K.; Sripaipan, T.; Suriyanon, V.; Celentano, D.D. 2005: HIV infection among female drug users in Northern Thailand. Drug and Alcohol Dependence 78(2): 141-145
Galati, V.; Serraino, D.; Puro, V.; Orchi, N.; De Carli, G.; Scognamiglio, P.; Nicastri, E.; Piselli, P.; Nurra, G.; Angeletti, C.; Girardi, E.; Ippolito, G. 2005: HIV infection among low-risk first lifetime testers in Rome, 1990-2000. Infection 33(2): 61-65
Verachai, V.; Phutiprawan, T.; Sawanpanyalert, P. 2005: HIV infection among substance abusers in Thanyarak Institute On Drug Abuse, Thailand, 1987-2002. Journal of the Medical Association of Thailand 88(1): 76-79
Shuhart, M.C.; Sullivan, D.G.; Bekele, K.; Harrington, R.D.; Kitahata, M.M.; Mathisen, T.L.; Thomassen, L.V.; Emerson, S.S.; Gretch, D.R. 2006: HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability. Journal of Infectious Diseases 193(9): 1211-1218
Arnsten, J.H.; Freeman, R.; Howard, A.A.; Floris-Moore, M.; Santoro, N.; Schoenbaum, E.E. 2006: HIV infection and bone mineral density in middle-aged women. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 42(7): 1014-1020
Valcour, V.; Paul, R. 2006: HIV infection and dementia in older adults. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 42(10): 1449-1454
Pol, S.; Lebray, P.; Vallet-Pichard, A. 2004: HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 38(Suppl 2): S65-S72
Rose, H.; Woolley, I.; Hoy, J.; Dart, A.; Bryant, B.; Mijch, A.; Sviridov, D. 2006: HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment. Metabolism, Clinical and Experimental 55(1): 90-95
Vaswani, M.; Desai, N.G. 2004: HIV infection and high-risk behaviors in opioid dependent patients: the Indian context. Addictive Behaviors 29(8): 1699-1705
Casper, C.; Redman, M.; Huang, M.-L.; Pauk, J.; Lampinen, T.M.; Hawes, S.E.; Critchlow, C.W.; Morrow, R.A.; Corey, L.; Kiviat, N.; Wald, A. 2004: HIV infection and human herpesvirus-8 oral shedding among men who have sex with men. Journal of Acquired Immune Deficiency Syndromes 35(3): 233-238
Shrivastava, S.K.; Engineer, R.; Rajadhyaksha, S.; Dinshaw, K.A. 2005: HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 74(1): 31-35
Valadas, Eília.; Hänscheid, T.; Antunes, F. 2004: HIV Infection and non-tuberculous mycobacteria: how important in southern European countries?. Scandinavian Journal of Infectious Diseases 36(9): 685-686
Larin, F.I.; Lebedev, V.V.; Red'ko, A.N. 2005: HIV infection and parenteral virus hepatitis in the Krasnodar territory. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2005(3): 78-79
Gregson, S.; Nyamukapa, C.A.; Garnett, G.P.; Wambe, M.; Lewis, J.J.C.; Mason, P.R.; Chandiwana, S.K.; Anderson, R.M. 2005: HIV infection and reproductive health in teenage women orphaned and made vulnerable by AIDS in Zimbabwe. Aids Care 17(7): 785-794
Varela-Ramirez, A.; Mejia, A.; Garcia, D.; Bader, J.; Aguilera, R.J. 2005: HIV infection and risk behavior of Hispanic farm workers at the west Texas-Mexico border. Ethnicity and Disease 15(4 Suppl 5): S5
Ding, Y.; Detels, R.; Zhao, Z.; Zhu, Y.; Zhu, G.; Zhang, B.; Shen, T.; Xue, X. 2005: HIV infection and sexually transmitted diseases in female commercial sex workers in China. Journal of Acquired Immune Deficiency Syndromes 38(3): 314-319
Wade, A.Sidibe.; Kane, C.Toure.; Diallo, P.Amadou.Niang.; Diop, A.Khoudia.; Gueye, K.; Mboup, S.; Ndoye, I.; Lagarde, E. 2005: HIV infection and sexually transmitted infections among men who have sex with men in Senegal. Aids 19(18): 2133-2140
Atalay, A.çe.; Ozdemir, O.; Guven, G.S.; Başgöze, O. 2006: HIV infection and shoulder pain: a challenging case. Rheumatology International 26(7): 680-682
Qureshi, A.I. 2005: HIV infection and stroke: if not protein S deficiency then what explains the relationship?. Journal of Neurology Neurosurgery and Psychiatry 76(10): 1331
Sia, J.; Paul, S.; Martin, R.M.; Cross, H. 2004: HIV infection and zidovudine use in childbearing women. Pediatrics 114(6): E707-E712
Nunes, D.; Fleming, C.; Offner, G.; O'Brien, M.; Tumilty, S.; Fix, O.; Heeren, T.; Koziel, M.; Graham, C.; Craven, D.E.; Stuver, S.; Horsburgh, C.Robert. 2005: HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. Journal of Acquired Immune Deficiency Syndromes 40(5): 538-544
Grabar, S.; Weiss, L.; Costagliola, D. 2006: HIV infection in older patients in the HAART era. Journal of Antimicrobial ChemoTherapy 57(1): 4-7
Orlova, O.A.; Karazhas, N.V.; Rusakova, E.V. 2005: HIV infection in pregnant women in Chelyabinsk. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2005(1): 73-74
Santos, Jús.; Palacios, R.; Gutierrez, Mónica.; Grana, M.; de la Torre, J.; Salgado, F.; Nuño, E.; Márquez, M. 2004: HIV infection in the era of highly active antiretroviral therapy: the Malaga Study. International Journal of Std and Aids 15(9): 594-596
Leal, D.B.R.; Streher, C.A.; Bertoncheli, C.d.M.; Carli, L.F.D.; Leal, C.A.M.; da Silva, J.é E.P.; Morsch, V.M.; Schetinger, M.R.C. 2005: HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes. Biochimica et Biophysica Acta 1746(2): 129-134
Oswald-Richter, K.; Grill, S.M.; Shariat, N.; Leelawong, M.; Sundrud, M.S.; Haas, D.W.; Unutmaz, D. 2004: HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. Plos Biology 2(7): E198
Oswald-Richter, K.; Grill, S.M.; Leelawong, M.; Unutmaz, D. 2004: HIV infection of primary human T cells is determined by tunable thresholds of T cell activation. European Journal of Immunology 34(6): 1705-1714
Dion, M-Lise.; Poulin, J-François.; Bordi, R.; Sylvestre, M.; Corsini, R.; Kettaf, N.; Dalloul, A.; Boulassel, M-Rachid.; Debré, P.; Routy, J-Pierre.; Grossman, Z.; Sékaly, R-Pierre.; Cheynier, Rémi. 2004: HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 21(6): 757-768
Adams, A.L.; Becker, T.M.; Lapidus, J.A.; Modesitt, S.K.; Lehman, J.Stan.; Loveless, M.O. 2003: HIV infection risk, behaviors, and attitudes about testing: are perceptions changing?. Sexually Transmitted Diseases 30(10): 764-768
Hürlimann, D.; Weber, R.; Enseleit, F.; Lüscher, T.F. 2005: HIV infection, antiretroviral therapy, and endothelium. Herz 30(6): 472-480
Manfredi, R. 2003: HIV infection, antiretroviral therapy, and hepatic function. Emerging epidemiological, pathogenetic, and clinical issues, and their consequences on disease management. Aids 17(15): 2253-2256
Schoenbaum, E.E.; Hartel, D.; Lo, Y.; Howard, A.A.; Floris-Moore, M.; Arnsten, J.H.; Santoro, N. 2005: HIV infection, drug use, and onset of natural menopause. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 41(10): 1517-1524
Kottilil, S.; Polis, M.A.; Kovacs, J.A. 2004: HIV Infection, hepatitis C infection, and HAART: hard clinical choices. JAMA 292(2): 243-250
Anekthananon, T.; Ratanasuwan, W.; Techasathit, W.; Rongrungruang, Y.; Suwanagool, S. 2004: HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention. Journal of the Medical Association of Thailand 87(2): 173-179
Beq, S.ép.; Rannou, M.-T.ér.ès.; Fontanet, A.; Delfraissy, J.-F.ço.; Thèze, J.; Colle, J.-H.é 2004: HIV infection: pre-highly active antiretroviral therapy IL-7 plasma levels correlate with long-term CD4 cell count increase after treatment. Aids 18(3): 563-565
Hel, Z.; McGhee, J.R.; Mestecky, J. 2006: HIV infection: first battle decides the war. Trends in Immunology 27(6): 274-281
Yamaguchi, J.; Bodelle, P.; Vallari, A.S.; Coffey, R.; McArthur, C.P.; Schochetman, G.; Devare, S.G.; Brennan, C.A. 2004: HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections. Aids Research and Human Retroviruses 20(9): 944-957
Nair, V.; Chi, G.; Ptak, R.; Neamati, N. 2006: HIV integrase inhibitors with nucleobase scaffolds: discovery of a highly potent anti-HIV agent. Journal of Medicinal Chemistry 49(2): 445-447
Hesketh, T.; Zhang, J.; Qiang, D.J. 2005: HIV knowledge and risk behaviour of female sex workers in Yunnan Province, China: potential as bridging groups to the general population. Aids Care 17(8): 958-966
Budowle, B.; Harmon, R. 2005: HIV legal precedent useful for microbial forensics. Croatian Medical Journal 46(4): 514-521
Hutchinson, G. 2005: HIV mania as a marker for clinical deterioration in AIDS. West Indian Medical Journal 54(2): 149-151
Couturier, J.P.; Root-Bernstein, R.S. 2005: HIV may produce inhibitory micro RNAs (miRNAs) that block production of CD28, CD4 and some interleukins. Journal of Theoretical Biology 235(2): 169-184
Jin, Y-Jiu.; Cai, C.Yi.; Zhang, X.; Zhang, H-Tang.; Hirst, J.A.; Burakoff, S.J. 2005: HIV Nef-mediated CD4 down-regulation is adaptor protein complex 2 dependent. Journal of Immunology 175(5): 3157-3164
Estanislao, L.; Thomas, D.; Simpson, D. 2004: HIV neuromuscular disease and mitochondrial function. Mitochondrion 4(2-3): 131-139
Simpson, D.M.; Kitch, D.; Evans, S.R.; McArthur, J.C.; Asmuth, D.M.; Cohen, B.; Goodkin, K.; Gerschenson, M.; So, Y.; Marra, C.M.; Diaz-Arrastia, R.; Shriver, S.; Millar, L.; Clifford, D.B. 2006: HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology 66(11): 1679-1687
Betts, M.R.; Nason, M.C.; West, S.M.; De Rosa, S.C.; Migueles, S.A.; Abraham, J.; Lederman, M.M.; Benito, J.M.; Goepfert, P.A.; Connors, M.; Roederer, M.; Koup, R.A. 2006: HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107(12): 4781-4789
De Francesco, M.A.; Poiesi, C.; Ricotta, D.; Manca, N. 2006: HIV p17 reverses the anti-inflammatory activity of IL-4 on IL-15 stimulated monocytes and modulates their ability to secrete MIP-1 alpha. Virus Research 118(1-2): 170-177
Golden, M.R.; Hogben, M.; Potterat, J.J.; Handsfield, H.Hunter. 2004: HIV partner notification in the United States: a national survey of program coverage and outcomes. Sexually Transmitted Diseases 31(12): 709-712
Tomnay, J.E.; Hatch, B.A.; Pitts, M.K.; Carter, T.R.; Fairley, C.K. 2004: HIV partner notification: a 2002 Victorian audit. International Journal of Std and Aids 15(9): 629-631
Foster, J.L.; Garcia, J.V. 2006: HIV pathogenesis: Nef loses control. Cell 125(6): 1034-1035
Stone, S.F.; Price, P.; Khan, N.; Moss, P.A.; French, M.A. 2005: HIV patients on antiretroviral therapy have high frequencies of CD8 T cells specific for Immediate Early protein-1 of cytomegalovirus. Aids 19(6): 555-562
Y.ge, Tadashi 2004: HIV positive patients in international medical center of Japan. Jibi Inkoka Tokeibu Geka 76(3): 210-213
Hope, V.D.; Judd, A.; Hickman, M.; Sutton, A.; Stimson, G.V.; Parry, J.V.; Gill, O.Noel. 2005: HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years. Aids 19(11): 1207-1214
Magis-Rodríguez, C.; Brouwer, K.C.; Morales, S.; Gayet, C.; Lozada, R.; Ortiz-Mondragón, R.; Ricketts, E.P.; Strathdee, S.A. 2005: HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.s. border city of Tijuana. Journal of Psychoactive Drugs 37(3): 333-339
Samnang, P.; Leng, H.B.; Kim, A.; Canchola, A.; Moss, A.; Mandel, J.S.; Page-Shafer, K. 2004: HIV prevalence and risk factors among fishermen in Sihanouk Ville, Cambodia. International Journal of Std and Aids 15(7): 479-483
Xia, Q.; Osmond, D.H.; Tholandi, M.; Pollack, L.M.; Zhou, W.; Ruiz, J.D.; Catania, J.A. 2006: HIV prevalence and sexual risk behaviors among men who have sex with men: results from a statewide population-based survey in California. Journal of Acquired Immune Deficiency Syndromes 41(2): 238-245
Asamoah-Odei, E.; Garcia Calleja, J.M.; Boerma, J.T. 2004: HIV prevalence and trends in sub-Saharan Africa: no decline and large subregional differences. Lancet 364(9428): 35-40
Cortina-Borja, M.; Cliffe, S.; Tookey, P.; Williams, D.; Cubitt, W.David.; Peckham, C. 2004: HIV prevalence in pregnant women in an ethnically diverse population in the UK: 1998-2002. Aids 18(3): 535-540
Leukefeld, C.; Roberto, H.; Hiller, M.; Webster, M.; Logan, T.K.; Staton-Tindall, M. 2003: HIV prevention among high-risk and hard-to-reach rural residents. Journal of psychoactive drugs 35(4): 427-434
Basu, I.; Jana, S.; Rotheram-Borus, M.Jane.; Swendeman, D.; Lee, S-Jae.; Newman, P.; Weiss, R. 2004: HIV prevention among sex workers in India. Journal of Acquired Immune Deficiency Syndromes 36(3): 845-852
Thorburn, S.; Harvey, S.M.; Ryan, E.A. 2005: HIV prevention heuristics and condom use among African-Americans at risk for HIV. Aids Care 17(3): 335-344
Amirkhanian, Y.A.; Kelly, J.A.; Benotsch, E.G.; Somlai, A.M.; Brown, K.D.; Fernandez, M.I.; Opgenorth, K.M. 2004: HIV prevention nongovernmental organizations in Central and Eastern Europe: programs, resources and challenges. Central European Journal of Public Health 12(1): 12-18
Gahery, H.; Choppin, J.; Bourgault, I.; Fischer, E.; Maillère, B.; Guillet, J-Gèrard. 2005: HIV preventive vaccine research at the ANRS: the lipopeptide vaccine approach. Therapie 60(3): 243-248
Alvarez, E.; Castelló, A.; Menéndez-Arias, L.; Carrasco, L. 2006: HIV protease cleaves poly(A)-binding protein. Biochemical Journal 396(2): 219-226
Yamamoto, N.; Yang, R.; Yoshinaka, Y.; Amari, S.; Nakano, T.; Cinatl, J.; Rabenau, H.; Doerr, H.W.; Hunsmann, G.; Otaka, A.; Tamamura, H.; Fujii, N.; Yamamoto, N. 2004: HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochemical and Biophysical Research Communications 318(3): 719-725
Conklin, B.S.; Fu, W.; Lin, P.H.; Lumsden, A.B.; Yao, Q.; Chen, C. 2004: HIV protease inhibitor ritonavir decreases endothelium-dependent vasorelaxation and increases superoxide in porcine arteries. Cardiovascular Research 63(1): 168-175
Chen, C.; Lu, X.-H.; Yan, S.; Chai, H.; Yao, Q. 2005: HIV protease inhibitor ritonavir increases endothelial monolayer permeability. Biochemical and Biophysical Research Communications 335(3): 874-882
Goetzman, E.S.; Tian, L.; Nagy, T.R.; Gower, B.A.; Schoeb, T.R.; Elgavish, A.; Acosta, E.P.; Saag, M.S.; Wood, P.A. 2003: HIV protease inhibitor ritonavir induces lipoatrophy in male mice. Aids Research and Human Retroviruses 19(12): 1141-1150
Lichtner, M.; Mengoni, F.; Mastroianni, C.M.; Sauzullo, I.; Rossi, R.; De Nicola, M.; Vullo, V.; Ghibelli, L. 2006: HIV protease inhibitor therapy reverses neutrophil apoptosis in AIDS patients by direct calpain inhibition. Apoptosis: An International Journal on Programmed Cell Death 11(5): 781-787
Zhou, H.; Gurley, E.C.; Jarujaron, S.; Ding, H.; Fang, Y.; Xu, Z.; Pandak, W.M.; Hylemon, P.B. 2006: HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes. American Journal of Physiology. Gastrointestinal and Liver Physiology 291(6): G1071-G1080
Zhou, H.; Pandak, W.M.; Lyall, V.; Natarajan, R.; Hylemon, P.B. 2005: HIV protease inhibitors activate the unfolded protein response in macrophages: implication for atherosclerosis and cardiovascular disease. Molecular Pharmacology 68(3): 690-700
Gupta, A.; Zhang, Y.; Unadkat, J.D.; Mao, Q. 2004: HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2). Journal of Pharmacology and Experimental Therapeutics 310(1): 334-341
Gupta, A.K.; Cerniglia, G.J.; Mick, R.; McKenna, W.G.; Muschel, R.J. 2005: HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo. Cancer Research 65(18): 8256-8265
Kudlow, B.A.; Jameson, S.A.; Kennedy, B.K. 2005: HIV protease inhibitors block adipocyte differentiation independently of lamin A/C. Aids 19(15): 1565-1573
Neye, Y.; Düfer, M.; Drews, G.; Krippeit-Drews, P. 2005: HIV protease inhibitors: suppression of insulin secretion by inhibition of voltage-dependent K+ currents and anion currents. Journal of Pharmacology and Experimental Therapeutics 316(1): 106-112
O'Loughlin, T.L.; Matsumura, I. 2006: HIV protease-activated molecular switches based on beta-glucuronidase and alkaline phosphatase. Combinatorial Chemistry and High Throughput Screening 9(4): 313-320
Clark, J.P.; Sampair, C.S.; Kofuji, P.; Nath, A.; Ding, J.M. 2005: HIV protein, transactivator of transcription, alters circadian rhythms through the light entrainment pathway. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 289(3): R656-R662
Fraser, C. 2006: HIV recombination: what is the impact on antiretroviral therapy?. Journal of the Royal Society Interface 2(5): 489-503
Wainberg, M.A. 2003: HIV resistance to nevirapine and other non-nucleoside reverse transcriptase inhibitors. Journal of Acquired Immune Deficiency Syndromes 34(Suppl): S2-S7
Ren, J.; Stammers, D.K. 2005: HIV reverse transcriptase structures: designing new inhibitors and understanding mechanisms of drug resistance. Trends in Pharmacological Sciences 26(1): 4-7
Prestage, G.; Mao, L.; McGuigan, D.; Crawford, J.; Kippax, S.; Kaldor, J.; Grulich, A.E. 2005: HIV risk and communication between regular partners in a cohort of HIV-negative gay men. Aids Care 18(2): 166-172
Grémy, I.; Beltzer, N. 2004: HIV risk and condom use in the adult heterosexual population in France between 1992 and 2001: return to the starting point?. Aids 18(5): 805-809